Goldman Sachs has filed an updated Schedule 13G/A, revealing a 0.9% stake in Karyopharm Therapeutics, signaling continued interest in the pharmaceutical sector.
| Name | Karyopharm Therapeutics Inc. |
|---|---|
| CIK | 0001503802 |
| Tickers | KPTIQ, KPTI |
| Exchanges | , Nasdaq |
| Entity type | operating |
| Category | Non-accelerated filer<br>Smaller reporting company |
| SIC | 2834 Pharmaceutical Preparations |
| EIN | 263931704 |
| LEI | — |
| Fiscal year end | 1231 |
| State of incorporation | DE DE |
| Phone | 617-658-0600 |
| Website | — |
| Investor website | — |
| Owner org | 03 Life Sciences |
| Flags | — |
| Description | — |
| Insider transactions (issuer) | 1 |
| Insider transactions (owner) | 0 |
EDGAR has no company-logo API. Website field is shown when the filer provided one.
Goldman Sachs has filed an updated Schedule 13G/A, revealing a 0.9% stake in Karyopharm Therapeutics, signaling continued interest in the pharmaceutical sector.
Karyopharm Therapeutics Inc. faces delisting from Nasdaq following its Chapter 11 filing, transitioning to over-the-counter trading under a new symbol.
Karyopharm Therapeutics Inc. has filed for Chapter 11 bankruptcy, seeking to restructure and maximize value amid financial challenges.
Karyopharm Therapeutics has entered a merger agreement with Ayrmid Ltd. as part of its Chapter 11 restructuring, aiming to enhance its operations in the pharmaceutical sector.
Karyopharm Therapeutics reports new investment from Integrated Core Strategies, reflecting continued interest in the pharmaceutical sector.
Karyopharm Therapeutics extends its forbearance agreement, giving the company until November 1, 2026, to address financial obligations amid ongoing challenges.
Karyopharm Therapeutics Inc. extends its forbearance agreement, providing more time to address financial obligations amid ongoing industry challenges.
1157 filing rows loaded from submissions recent; extra archives: CIK0001503802-submissions-001.json (156 filings, 2010-11-05 to 2015-04-05).
| Filed | Form | Document | Items | Accession | File no. | Film | Act | Size | XBRL | iXBRL |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-11-16 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0001346824-26-000285 | 005-87705 | 261562790 | 34 | 15414 | |||
| 2026-11-13 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0001011438-26-000695 | 005-87705 | 261552709 | 34 | 10680 | |||
| 2026-11-13 | NT 10-Q | NT 10-Q | 0001193125-26-460615 | 001-36167 | 261552435 | 34 | 31248 | |||
| 2026-11-12 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0000919574-26-007570 | 005-87705 | 261543934 | 34 | 13201 | |||
| 2026-11-09 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0000886982-26-000549 | 005-87705 | 261535200 | 34 | 18434 | |||
| 2026-11-05 | 8-K | 8-K | 3.01 | 0001193125-26-448516 | 001-36167 | 261524645 | 34 | 147316 | 1 | 1 |
| 2026-11-03 | 8-K | 8-K | 1.01,1.03,2.03,2.04,7.01,8.01,9.01 | 0001193125-26-444164 | 001-36167 | 261514188 | 34 | 2716136 | 1 | 1 |
| 2026-11-02 | 8-K | 8-K | 7.01,9.01 | 0001193125-26-442822 | 001-36167 | 261510167 | 34 | 167937 | 1 | 1 |
| 2026-10-28 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0001104659-26-119710 | 005-87705 | 261496812 | 34 | 19481 | |||
| 2026-10-22 | 8-K | 8-K | 8.01 | 0001193125-26-428938 | 001-36167 | 261479044 | 34 | 137252 | 1 | 1 |
| 2026-10-19 | 4 | 4 | 0001193125-26-425227 | 5018 | ||||||
| 2026-10-14 | 8-K | 8-K | 8.01 | 0001193125-26-421025 | 001-36167 | 261458278 | 34 | 136982 | 1 | 1 |
| 2026-10-08 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0001636587-26-000086 | 005-87705 | 261448637 | 34 | 12520 | |||
| 2026-10-02 | 4 | 4 | 0001193125-26-412209 | 5016 | ||||||
| 2026-09-25 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0001636587-26-000084 | 005-87705 | 261409544 | 34 | 12520 | |||
| 2026-09-25 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0001636587-26-000083 | 005-87705 | 261407147 | 34 | 12515 | |||
| 2026-09-18 | 8-K | 8-K | 3.03,5.03,9.01 | 0001193125-26-395517 | 001-36167 | 261390849 | 34 | 656108 | 1 | 1 |
| 2026-09-11 | 8-K | 8-K | 1.01,2.04,3.02,8.01,9.01 | 0001193125-26-388621 | 001-36167 | 261372688 | 34 | 564519 | 1 | 1 |
| 2026-09-04 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0001104659-26-105556 | 005-87705 | 261362928 | 34 | 18720 | |||
| 2026-09-02 | 4 | 4 | 0001193125-26-380404 | 5015 | ||||||
| 2026-08-31 | 8-K | 8-K | 8.01 | 0001193125-26-375495 | 001-36167 | 261342605 | 34 | 145572 | 1 | 1 |
| 2026-08-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0001231919-26-000925 | 005-87705 | 261283055 | 34 | 15498 | |||
| 2026-08-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0001831942-26-000037 | 005-87705 | 261281777 | 34 | 14095 | |||
| 2026-08-13 | 10-Q | 10-Q | 0001193125-26-347906 | 001-36167 | 261270090 | 34 | 12185166 | 1 | 1 | |
| 2026-08-13 | 8-K | 8-K | 2.02,9.01 | 0001193125-26-347897 | 001-36167 | 261270083 | 34 | 535609 | 1 | 1 |
| 2026-08-12 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0000919574-26-004964 | 005-87705 | 261266223 | 34 | 13108 | |||
| 2026-08-11 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0000886982-26-000401 | 005-87705 | 261265034 | 34 | 18361 | |||
| 2026-07-31 | 8-K | 8-K | 8.01 | 0001193125-26-326995 | 001-36167 | 261225546 | 34 | 152475 | 1 | 1 |
| 2026-07-30 | 4 | 4 | 0001193125-26-326290 | 4979 | ||||||
| 2026-07-28 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0002012383-26-002546 | 005-87705 | 261212582 | 34 | 10801 | |||
| 2026-07-17 | 8-K | 8-K | 5.02 | 0001193125-26-307964 | 001-36167 | 261184400 | 34 | 139116 | 1 | 1 |
| 2026-06-05 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0001897612-26-000511 | 005-87705 | 261067626 | 34 | 7684 | |||
| 2026-05-28 | 8-K | 8-K | 5.02,5.07,9.01 | 0001503802-26-000027 | 001-36167 | 261035950 | 34 | 233292 | 1 | 1 |
| 2026-05-27 | S-8 | S-8 | 0001193125-26-242089 | 333-296281 | 261027293 | 33 | 179916 | 1 | 1 | |
| 2026-05-27 | S-8 | S-8 | 0001193125-26-242083 | 333-296280 | 261027266 | 33 | 185278 | 1 | 1 | |
| 2026-05-26 | 4 | 4 | 0001822092-26-000004 | 5034 | ||||||
| 2026-05-26 | 4 | 4 | 0001270734-26-000002 | 5063 | ||||||
| 2026-05-26 | 4 | 4 | 0001340875-26-000005 | 5050 | ||||||
| 2026-05-26 | 4 | 4 | 0001991642-26-000002 | 5007 | ||||||
| 2026-05-26 | 4 | 4 | 0001254705-26-000008 | 5273 | ||||||
| 2026-05-26 | 4 | 4 | 0001291963-26-000004 | 5282 | ||||||
| 2026-05-15 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0001193125-26-227136 | 005-87705 | 26989424 | 34 | 152772 | |||
| 2026-05-15 | 4 | 4 | 0001193125-26-226697 | 6932 | ||||||
| 2026-05-15 | 4 | 4 | 0001193125-26-226685 | 6994 | ||||||
| 2026-05-15 | 4 | 4 | 0001193125-26-226652 | 6843 | ||||||
| 2026-05-15 | 4 | 4 | 0001193125-26-226616 | 7207 | ||||||
| 2026-05-15 | 4 | 4 | 0001193125-26-226613 | 6932 | ||||||
| 2026-05-15 | 4 | 4 | 0001193125-26-226604 | 6941 | ||||||
| 2026-05-15 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0001636587-26-000031 | 005-87705 | 26985988 | 34 | 12518 | |||
| 2026-05-14 | EFFECT | xslEFFECTX01/primary_doc.xml | ,, | 9999999995-26-001656 | 333-295535 | 26981806 | 33 | 1757 | ||
| 2026-05-14 | EFFECT | xslEFFECTX01/primary_doc.xml | ,, | 9999999995-26-001655 | 333-295533 | 26981804 | 33 | 1757 | ||
| 2026-05-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0001011438-26-000310 | 005-87705 | 26978768 | 34 | 10123 | |||
| 2026-05-14 | 10-Q | 10-Q | 0001193125-26-222827 | 001-36167 | 26975884 | 34 | 10979914 | 1 | 1 | |
| 2026-05-14 | 8-K | 8-K | 2.02,9.01 | 0001193125-26-222808 | 001-36167 | 26975861 | 34 | 473361 | 1 | 1 |
| 2026-05-13 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0000919574-26-002939 | 005-87705 | 26971301 | 34 | 16939 | |||
| 2026-05-12 | CORRESP | filename1.htm | 0001193125-26-219351 | 6423 | ||||||
| 2026-05-12 | CORRESP | filename1.htm | 0001193125-26-219339 | 6423 | ||||||
| 2026-05-12 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0000886982-26-000235 | 005-87705 | 26968232 | 34 | 18167 | |||
| 2026-05-11 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0001493152-26-022238 | 005-87705 | 26963541 | 34 | 22962 | |||
| 2026-05-07 | UPLOAD | filename1.pdf | 0000000000-26-004695 | 333-295535 | 147902 | |||||
| 2026-05-07 | UPLOAD | filename1.pdf | 0000000000-26-004694 | 333-295533 | 147900 | |||||
| 2026-05-04 | S-3 | S-3 | 0001193125-26-204134 | 333-295535 | 26938409 | 33 | 893482 | 1 | 1 | |
| 2026-05-04 | S-3 | S-3 | 0001193125-26-204130 | 333-295533 | 26938385 | 33 | 1591162 | 1 | 1 | |
| 2026-04-22 | 4 | 4 | 0001825322-26-000006 | 5040 | ||||||
| 2026-04-13 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0001104659-26-042704 | 005-87705 | 26858628 | 34 | 18309 | |||
| 2026-04-13 | ARS | ARS | 0001503802-26-000024 | 001-36167 | 26856532 | 34 | 2514289 | |||
| 2026-04-13 | DEF 14A | DEF 14A | 0001503802-26-000023 | 001-36167 | 26856528 | 34 | 5991328 | 1 | 1 | |
| 2026-04-02 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0001346824-26-000092 | 005-87705 | 26834718 | 34 | 19976 | |||
| 2026-04-02 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0001831942-26-000015 | 005-87705 | 26834107 | 34 | 15009 | |||
| 2026-03-27 | 8-K | 8-K | 8.01 | 0001503802-26-000011 | 001-36167 | 26801151 | 34 | 173864 | 1 | 1 |
| 2026-03-24 | 8-K | 8-K | 1.01,3.02,7.01,8.01,9.01 | 0001193125-26-120770 | 001-36167 | 26784224 | 34 | 10110148 | 1 | 1 |
| 2026-03-03 | 4 | 4 | 0002045943-26-000003 | 4880 | ||||||
| 2026-03-03 | 4 | 4 | 0001837741-26-000003 | 4853 | ||||||
| 2026-03-03 | 4 | 4 | 0001865796-26-000003 | 4906 | ||||||
| 2026-03-03 | 4 | 4 | 0001825322-26-000003 | 4906 | ||||||
| 2026-03-03 | 4 | 4 | 0001804460-26-000003 | 4842 | ||||||
| 2026-03-03 | 4 | 4 | 0001942597-26-000003 | 4844 | ||||||
| 2026-03-03 | 8-K | 8-K | 1.01,8.01,9.01 | 0001503802-26-000006 | 001-36167 | 26709892 | 34 | 395592 | 1 | 1 |
| 2026-02-19 | 8-K | 8-K | 5.07 | 0001193125-26-059349 | 001-36167 | 26654359 | 34 | 189452 | 1 | 1 |
| 2026-02-19 | 4 | 4 | 0001193125-26-059332 | 4841 | ||||||
| 2026-02-17 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001897612-26-000267 | 005-87705 | 26637788 | 34 | 7571 | |||
| 2026-02-13 | 10-K | 10-K | 0001193125-26-049397 | 001-36167 | 26628442 | 34 | 20956478 | 1 | 1 | |
| 2026-02-12 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000902664-26-000896 | 005-87705 | 26623665 | 34 | 13023 | |||
| 2026-02-12 | 8-K | 8-K | 2.02,9.01 | 0001193125-26-047670 | 001-36167 | 26623431 | 34 | 550972 | 1 | 1 |
| 2026-02-10 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0001104659-26-012689 | 005-87705 | 26616793 | 34 | 18146 | |||
| 2026-02-09 | 4 | 4 | 0001193125-26-042799 | 4825 | ||||||
| 2026-02-04 | 4 | 4 | 0001193125-26-037584 | 4894 | ||||||
| 2026-02-03 | 4 | 4 | 0001193125-26-035687 | 4891 | ||||||
| 2026-02-03 | 4 | 4 | 0001193125-26-035682 | 4917 | ||||||
| 2026-02-03 | 4 | 4 | 0001193125-26-035663 | 4876 | ||||||
| 2026-02-03 | 4 | 4 | 0001193125-26-035661 | 4838 | ||||||
| 2026-02-03 | 4 | 4 | 0001193125-26-035655 | 4829 | ||||||
| 2026-01-29 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001315863-26-000103 | 005-87705 | 26580221 | 34 | 16552 | |||
| 2026-01-29 | 4 | 4 | 0001193125-26-029599 | 6798 | ||||||
| 2026-01-22 | 4 | 4 | 0001193125-26-019428 | 4878 | ||||||
| 2026-01-12 | 8-K | 8-K | 2.02,8.01,9.01 | 0001193125-26-009738 | 001-36167 | 26524628 | 34 | 314102 | 1 | 1 |
| 2026-01-09 | DEF 14A | DEF 14A | 0001193125-26-008939 | 001-36167 | 26523253 | 34 | 4354308 | |||
| 2025-12-30 | PRE 14A | PRE 14A | 0001193125-25-337113 | 001-36167 | 251614426 | 34 | 4355031 | |||
| 2025-11-24 | 424B3 | 424B3 | 0001193125-25-291933 | 333-291223 | 251509497 | 33 | 332541 | |||
| 2025-11-24 | 424B3 | 424B3 | 0001193125-25-291930 | 333-291224 | 251509490 | 33 | 299498 | |||
| 2025-11-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000902664-25-004954 | 005-87705 | 251482556 | 34 | 10646 | |||
| 2025-11-07 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001897612-25-000507 | 005-87705 | 251461662 | 34 | 7570 | |||
| 2025-11-03 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001493152-25-020601 | 005-87705 | 251444570 | 34 | 9634 | |||
| 2025-11-03 | S-3 | S-3 | 0001193125-25-262581 | 333-291224 | 251444298 | 33 | 520038 | 1 | 1 | |
| 2025-11-03 | S-3 | S-3 | 0001193125-25-262571 | 333-291223 | 251444240 | 33 | 557802 | 1 | 1 | |
| 2025-11-03 | 10-Q | 10-Q | 0001193125-25-261667 | 001-36167 | 251442100 | 34 | 12007220 | 1 | 1 | |
| 2025-11-03 | 8-K | 8-K | 2.02,9.01 | 0001193125-25-261663 | 001-36167 | 251442092 | 34 | 518649 | 1 | 1 |
| 2025-10-30 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000102909-25-000154 | 005-87705 | 251434813 | 34 | 6198 | |||
| 2025-10-17 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0001493152-25-018449 | 005-87705 | 251400824 | 34 | 23795 | |||
| 2025-10-17 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000019617-25-001004 | 005-87705 | 251400033 | 34 | 7251 | |||
| 2025-10-16 | 4 | 4 | 0001193125-25-241487 | 4906 | ||||||
| 2025-10-16 | 4 | 4 | 0001193125-25-241484 | 4760 | ||||||
| 2025-10-16 | 4 | 4 | 0001193125-25-241479 | 4781 | ||||||
| 2025-10-16 | 4 | 4 | 0001193125-25-241471 | 4757 | ||||||
| 2025-10-16 | 4 | 4 | 0001193125-25-241468 | 4821 | ||||||
| 2025-10-16 | 4 | 4 | 0001193125-25-241461 | 5011 | ||||||
| 2025-10-14 | 8-K | 8-K | 1.01,2.03,8.01,9.01 | 0001193125-25-239015 | 001-36167 | 251391854 | 34 | 6556591 | 1 | 1 |
| 2025-10-08 | 8-K | 8-K | 1.01,2.02,2.03,3.02,5.02,7.01,8.01,9.01 | 0001193125-25-233983 | 001-36167 | 251381219 | 34 | 282630 | 1 | 1 |
| 2025-10-03 | 4 | 4 | 0001193125-25-230359 | 5304 | ||||||
| 2025-09-16 | 4 | 4 | 0001193125-25-205052 | 6801 | ||||||
| 2025-09-16 | 4 | 4 | 0001193125-25-205049 | 6823 | ||||||
| 2025-09-16 | 4 | 4 | 0001193125-25-205046 | 6802 | ||||||
| 2025-09-16 | 4 | 4 | 0001193125-25-205044 | 6864 | ||||||
| 2025-09-16 | 4 | 4 | 0001193125-25-205042 | 7110 | ||||||
| 2025-09-16 | 4 | 4 | 0001193125-25-205038 | 7084 | ||||||
| 2025-09-11 | 8-K | 8-K | 5.02 | 0001503802-25-000006 | 001-36167 | 251308940 | 34 | 178844 | 1 | 1 |
| 2025-09-04 | 4 | 4 | 0002045943-25-000004 | 4877 | ||||||
| 2025-08-14 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0001897612-25-000365 | 005-87705 | 251216254 | 34 | 9213 | |||
| 2025-08-11 | S-8 | S-8 | 0001193125-25-177472 | 333-289466 | 251200251 | 33 | 177061 | 1 | 1 | |
| 2025-08-11 | 10-Q | 10-Q | 0000950170-25-106238 | 001-36167 | 251200197 | 34 | 11258231 | 1 | 1 | |
| 2025-08-11 | 8-K | 8-K | 2.02,9.01 | 0000950170-25-106236 | 001-36167 | 251200194 | 34 | 487174 | 1 | 1 |
| 2025-07-30 | 4 | 4 | 0000950170-25-100373 | 4842 | ||||||
| 2025-07-23 | 4 | 4 | 0000950170-25-097965 | 4877 | ||||||
| 2025-07-16 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0000019617-25-000528 | 005-87705 | 251126321 | 34 | 6618 | |||
| 2025-07-11 | 8-K | 8-K | 7.01,9.01 | 0000950170-25-095167 | 001-36167 | 251117501 | 34 | 29521706 | 1 | 1 |
| 2025-05-29 | 8-K | 8-K | 5.02,5.07,9.01 | 0000950170-25-079009 | 001-36167 | 251003851 | 34 | 224966 | 1 | 1 |
| 2025-05-29 | 4 | 4 | 0000950170-25-078974 | 5419 | ||||||
| 2025-05-29 | 4 | 4 | 0000950170-25-078961 | 5475 | ||||||
| 2025-05-29 | 4 | 4 | 0000950170-25-078956 | 5446 | ||||||
| 2025-05-29 | 4 | 4 | 0000950170-25-078950 | 5473 | ||||||
| 2025-05-29 | 4 | 4 | 0000950170-25-078944 | 5461 | ||||||
| 2025-05-29 | 4 | 4 | 0000950170-25-078938 | 5458 | ||||||
| 2025-05-29 | 4 | 4 | 0000950170-25-078937 | 5463 | ||||||
| 2025-05-12 | 10-Q | 10-Q | 0000950170-25-069231 | 001-36167 | 25935012 | 34 | 9271898 | 1 | 1 | |
| 2025-05-12 | 8-K | 8-K | 2.02,9.01 | 0000950170-25-069176 | 001-36167 | 25934778 | 34 | 445301 | 1 | 1 |
| 2025-05-07 | 4 | 4 | 0000950170-25-065884 | 4836 | ||||||
| 2025-04-24 | 4 | 4 | 0000950170-25-058137 | 4889 | ||||||
| 2025-04-14 | ARS | ARS | 0000950170-25-053516 | 001-36167 | 25834271 | 34 | 1461430 | |||
| 2025-04-14 | DEFA14A | DEFA14A | 0000950170-25-053514 | 001-36167 | 25834267 | 34 | 1404320 | |||
| 2025-04-14 | DEF 14A | DEF 14A | 0000950170-25-053511 | 001-36167 | 25834263 | 34 | 18072259 | 1 | 1 | |
| 2025-04-10 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0001999371-25-004117 | 005-87705 | 25829293 | 34 | 9983 | |||
| 2025-04-07 | 4 | 4 | 0000950170-25-051658 | 5278 | ||||||
| 2025-03-06 | 4 | 4 | 0000950170-25-034743 | 5351 | ||||||
| 2025-03-06 | 4 | 4 | 0000950170-25-034736 | 5287 | ||||||
| 2025-03-06 | 4 | 4 | 0000950170-25-034732 | 5339 | ||||||
| 2025-03-06 | 4 | 4 | 0000950170-25-034723 | 5290 | ||||||
| 2025-03-06 | 4 | 4 | 0000950170-25-034662 | 5325 | ||||||
| 2025-03-06 | 4 | 4 | 0000950170-25-034650 | 5311 | ||||||
| 2025-03-04 | 4 | 4 | 0000950170-25-032323 | 11769 | ||||||
| 2025-03-04 | 4 | 4 | 0000950170-25-032315 | 11530 | ||||||
| 2025-03-04 | 4 | 4 | 0000950170-25-032309 | 11482 | ||||||
| 2025-03-04 | 4 | 4 | 0000950170-25-032305 | 7600 | ||||||
| 2025-03-04 | 4 | 4 | 0000950170-25-032297 | 7563 | ||||||
| 2025-03-04 | 4 | 4 | 0000950170-25-032280 | 11500 | ||||||
| 2025-02-24 | 8-K | 8-K | 3.03,5.03,9.01 | 0000950170-25-025640 | 001-36167 | 25657216 | 34 | 206557 | 1 | 1 |
| 2025-02-19 | 4 | 4 | 0000950170-25-023192 | 4849 | ||||||
| 2025-02-19 | 10-K | 10-K | 0000950170-25-022765 | 001-36167 | 25637194 | 34 | 19441290 | 1 | 1 | |
| 2025-02-19 | 8-K | 8-K | 2.02,9.01 | 0000950170-25-022764 | 001-36167 | 25637185 | 34 | 521460 | 1 | 1 |
| 2025-02-12 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0000902664-25-000871 | 005-87705 | 25612654 | 34 | 16249 | |||
| 2025-02-05 | 4 | 4 | 0000950170-25-014491 | 4846 | ||||||
| 2025-02-03 | 4 | 4 | 0000950170-25-012326 | 7161 | ||||||
| 2025-01-31 | 8-K | 8-K | 5.02 | 0001193125-25-018385 | 001-36167 | 25578379 | 34 | 146107 | 1 | 1 |
| 2025-01-30 | 8-K | 8-K | 5.07 | 0001193125-25-017223 | 001-36167 | 25573695 | 34 | 154485 | 1 | 1 |
| 2025-01-13 | 8-K | 8-K | 2.02,9.01 | 0000950170-25-004591 | 001-36167 | 25524987 | 34 | 295938 | 1 | 1 |
| 2025-01-07 | 4 | 4 | 0000950170-25-002819 | 4847 | ||||||
| 2025-01-06 | 3 | 3 | 0000950170-25-002284 | 11338 | ||||||
| 2025-01-02 | 8-K | 8-K | 5.02,9.01 | 0000950170-25-000092 | 001-36167 | 25500213 | 34 | 255001 | 1 | 1 |
| 2024-12-16 | DEF 14A | DEF 14A | 0000950170-24-136598 | 001-36167 | 241551726 | 34 | 1686660 | |||
| 2024-12-05 | PRE 14A | PRE 14A | 0000950170-24-133728 | 001-36167 | 241529571 | 34 | 1692989 | |||
| 2024-12-05 | 4 | 4 | 0000950170-24-133689 | 4847 | ||||||
| 2024-12-03 | 8-K | 8-K | 7.01,9.01 | 0001193125-24-269398 | 001-36167 | 241521054 | 34 | 191807 | 1 | 1 |
| 2024-11-22 | 3 | 3 | 0000950170-24-130174 | 12014 | ||||||
| 2024-11-20 | 8-K | 8-K | 5.02 | 0001193125-24-262541 | 001-36167 | 241480482 | 34 | 146511 | 1 | 1 |
| 2024-11-14 | SC 13G/A | d11530516_13g-a.htm | 0000919574-24-006742 | 005-87705 | 241462817 | 34 | 178693 | |||
| 2024-11-12 | SC 13G/A | UnitedStates_13G__Karyopharm.txt | 0000932471-24-001032 | 005-87705 | 241447581 | 34 | 6550 | |||
| 2024-11-08 | 8-K | 8-K | 1.01,9.01 | 0000950170-24-124067 | 001-36167 | 241440481 | 34 | 275644 | 1 | 1 |
| 2024-11-06 | 4 | 4 | 0000950170-24-122274 | 5295 | ||||||
| 2024-11-05 | S-8 | S-8 | 0001193125-24-250994 | 333-282994 | 241425709 | 33 | 71966 | |||
| 2024-11-05 | 10-Q | 10-Q | 0000950170-24-121076 | 001-36167 | 241425674 | 34 | 9609711 | 1 | 1 | |
| 2024-11-05 | 8-K | 8-K | 2.02,9.01 | 0001193125-24-250984 | 001-36167 | 241425648 | 34 | 280681 | 1 | 1 |
| 2024-11-04 | SC 13G/A | UnitedStates_13G__Karyopharm.txt | 0000932471-24-000431 | 005-87705 | 241421703 | 34 | 5612 | |||
| 2024-10-31 | 8-K | 8-K | 7.01,8.01,9.01 | 0001193125-24-248162 | 001-36167 | 241412471 | 34 | 202636 | 1 | 1 |
| 2024-10-25 | SC 13G | KARYOPHARM THERAPEUTICS INC. | 0000902664-24-005987 | 005-87705 | 241394931 | 34 | 50081 | |||
| 2024-10-07 | 4 | 4 | 0000950170-24-113263 | 4849 | ||||||
| 2024-09-17 | 8-K | 8-K | 3.01 | 0001193125-24-220534 | 001-36167 | 241304346 | 34 | 147630 | 1 | 1 |
| 2024-09-05 | 4 | 4 | 0000950170-24-104038 | 4873 | ||||||
| 2024-09-05 | 4 | 4 | 0000950170-24-104033 | 4849 | ||||||
| 2024-09-05 | 4 | 4 | 0000950170-24-104031 | 4846 | ||||||
| 2024-09-05 | 4 | 4 | 0000950170-24-103998 | 5139 | ||||||
| 2024-08-29 | 8-K | 8-K | 5.02,9.01 | 0001193125-24-209907 | 001-36167 | 241263624 | 34 | 298733 | 1 | 1 |
| 2024-08-08 | 4 | 4 | 0000950170-24-094087 | 4849 | ||||||
| 2024-08-06 | 10-Q | 10-Q | 0000950170-24-091210 | 001-36167 | 241177138 | 34 | 9730552 | 1 | 1 | |
| 2024-08-06 | 8-K | 8-K | 2.02,9.01 | 0001193125-24-194427 | 001-36167 | 241177117 | 34 | 292583 | 1 | 1 |
| 2024-07-31 | 4 | 4 | 0000950170-24-088589 | 4851 | ||||||
| 2024-07-19 | SC TO-I/A | SC TO-I/A | 0001193125-24-181634 | 005-87705 | 241127873 | 34 | 16526 | |||
| 2024-07-09 | 4 | 4 | 0000950170-24-082417 | 4849 | ||||||
| 2024-07-08 | SC 13G/A | us48576u1060_070824.txt | 0001086364-24-008142 | 005-87705 | 241105125 | 34 | 12869 | |||
| 2024-06-20 | SC TO-I | SC TO-I | 0001193125-24-164000 | 005-87705 | 241054118 | 34 | 7208955 | |||
| 2024-06-07 | EFFECT | xslEFFECTX01/primary_doc.xml | S-3,,2024-06-07 16:30:00 | 9999999995-24-001788 | 333-279833 | 241031373 | 33 | 1765 | ||
| 2024-06-07 | 4 | 4 | 0000950170-24-070991 | 15119 | ||||||
| 2024-06-06 | 4 | 4 | 0000950170-24-069860 | 4845 | ||||||
| 2024-06-06 | 4 | 4 | 0000950170-24-069856 | 4849 | ||||||
| 2024-06-05 | CORRESP | filename1.htm | 0001193125-24-154766 | 6175 | ||||||
| 2024-06-04 | 4 | 4 | 0000950170-24-068969 | 15130 | ||||||
| 2024-06-03 | UPLOAD | filename1.pdf | 0000000000-24-006340 | 333-279833 | 40313 | |||||
| 2024-05-31 | 8-K | 8-K | 5.02,5.07,9.01 | 0001193125-24-151049 | 001-36167 | 241007744 | 34 | 168794 | 1 | 1 |
| 2024-05-30 | 4 | 4 | 0000950170-24-066787 | 5103 | ||||||
| 2024-05-30 | 4 | 4 | 0000950170-24-066786 | 5142 | ||||||
| 2024-05-30 | 4 | 4 | 0000950170-24-066785 | 5160 | ||||||
| 2024-05-30 | 4 | 4 | 0000950170-24-066784 | 5130 | ||||||
| 2024-05-30 | 4 | 4 | 0000950170-24-066782 | 5157 | ||||||
| 2024-05-30 | 4 | 4 | 0000950170-24-066781 | 5145 | ||||||
| 2024-05-30 | 4 | 4 | 0000950170-24-066771 | 5147 | ||||||
| 2024-05-30 | S-3 | S-3 | 0001193125-24-150438 | 333-279833 | 241006176 | 33 | 312497 | |||
| 2024-05-30 | S-8 | S-8 | 0001193125-24-150328 | 333-279823 | 241005226 | 33 | 71321 | |||
| 2024-05-23 | SC 13G | formsc13g.htm | 0001493152-24-021156 | 005-87705 | 24978747 | 34 | 113588 | |||
| 2024-05-14 | 8-K | 8-K | 8.01,9.01 | 0001193125-24-138211 | 001-36167 | 24944261 | 34 | 4837050 | 1 | 1 |
| 2024-05-08 | 10-Q | 10-Q | 0000950170-24-055672 | 001-36167 | 24926227 | 34 | 7376753 | 1 | 1 | |
| 2024-05-08 | 8-K | 8-K | 1.01,2.03,3.02,7.01,9.01 | 0001193125-24-133791 | 001-36167 | 24924285 | 34 | 223666 | 1 | 1 |
| 2024-05-08 | 8-K | 8-K | 2.02,9.01 | 0001193125-24-133784 | 001-36167 | 24924276 | 34 | 254196 | 1 | 1 |
| 2024-05-07 | 4 | 4 | 0000950170-24-054686 | 4846 | ||||||
| 2024-04-23 | 4 | 4 | 0000950170-24-046871 | 4898 | ||||||
| 2024-04-19 | ARS | ARS | 0001193125-24-101705 | 001-36167 | 24855643 | 34 | 2838232 | |||
| 2024-04-19 | DEFA14A | DEFA14A | 0000950170-24-045718 | 001-36167 | 24855635 | 34 | 1451592 | |||
| 2024-04-19 | DEF 14A | DEF 14A | 0000950170-24-045717 | 001-36167 | 24855627 | 34 | 7283256 | 1 | 1 | |
| 2024-04-18 | UPLOAD | filename1.pdf | 0000000000-24-004255 | 001-36167 | 39772 | |||||
| 2024-04-08 | SC TO-C | SC TO-C | 0001193125-24-089714 | 005-87705 | 24830406 | 34 | 28140 | |||
| 2024-04-08 | PRE 14A | PRE 14A | 0000950170-24-042645 | 001-36167 | 24830098 | 34 | 6428586 | 1 | 1 | |
| 2024-04-05 | 4 | 4 | 0000950170-24-042350 | 4846 | ||||||
| 2024-04-03 | CORRESP | filename1.htm | 0001193125-24-086060 | 62544 | ||||||
| 2024-03-21 | UPLOAD | filename1.pdf | 0000000000-24-003085 | 001-36167 | 43210 | |||||
| 2024-03-06 | 4 | 4 | 0000950170-24-027153 | 5288 | ||||||
| 2024-03-04 | 4 | 4 | 0000950170-24-025193 | 7151 | ||||||
| 2024-03-04 | 4 | 4 | 0000950170-24-025192 | 7101 | ||||||
| 2024-03-04 | 4 | 4 | 0000950170-24-025191 | 7096 | ||||||
| 2024-03-04 | 4 | 4 | 0000950170-24-025190 | 7122 | ||||||
| 2024-03-04 | 4 | 4 | 0000950170-24-025189 | 7162 | ||||||
| 2024-03-04 | 4 | 4 | 0000950170-24-025188 | 7101 | ||||||
| 2024-02-29 | 4 | 4 | 0000950170-24-023297 | 4854 | ||||||
| 2024-02-29 | 4 | 4 | 0000950170-24-023293 | 4806 | ||||||
| 2024-02-29 | 4 | 4 | 0000950170-24-023292 | 6591 | ||||||
| 2024-02-29 | 4 | 4 | 0000950170-24-023290 | 4827 | ||||||
| 2024-02-29 | 4 | 4 | 0000950170-24-023285 | 4867 | ||||||
| 2024-02-29 | 4 | 4 | 0000950170-24-023281 | 4802 | ||||||
| 2024-02-29 | 10-K | 10-K | 0000950170-24-022650 | 001-36167 | 24698907 | 34 | 16853272 | 1 | 1 | |
| 2024-02-29 | 8-K | 8-K | 2.02,9.01 | 0001193125-24-051845 | 001-36167 | 24698897 | 34 | 280122 | 1 | 1 |
| 2024-02-20 | 4 | 4 | 0000950170-24-017237 | 6249 | ||||||
| 2024-02-20 | 8-K | 8-K | 8.01 | 0001193125-24-039387 | 001-36167 | 24650798 | 34 | 144368 | 1 | 1 |
| 2024-02-14 | SC 13G/A | karypharm.htm | 0001306923-24-000004 | 005-87705 | 24639837 | 34 | 12003 | |||
| 2024-02-14 | SC 13G/A | d10982472_13g-a.htm | 0000919574-24-001291 | 005-87705 | 24633802 | 34 | 218849 | |||
| 2024-02-13 | SC 13G | SCHEDULE 13G | 0001104659-24-021272 | 005-87705 | 24628737 | 34 | 13043 | |||
| 2024-02-12 | SC 13G/A | SC 13G/A | 0001104659-24-013556 | 005-87705 | 24617225 | 34 | 77153 | |||
| 2024-02-08 | 4 | 4 | 0000950170-24-012832 | 4845 | ||||||
| 2024-02-08 | 4 | 4 | 0000950170-24-012824 | 4847 | ||||||
| 2024-01-25 | 4 | 4 | 0000950170-24-007621 | 5361 | ||||||
| 2024-01-25 | 4 | 4 | 0000950170-24-007614 | 5119 | ||||||
| 2024-01-25 | 4 | 4 | 0000950170-24-007610 | 5071 | ||||||
| 2024-01-25 | 4 | 4 | 0000950170-24-007589 | 5091 | ||||||
| 2024-01-25 | 4 | 4 | 0000950170-24-007588 | 5064 | ||||||
| 2024-01-25 | 4 | 4 | 0000950170-24-007583 | 5066 | ||||||
| 2024-01-25 | SC 13G/A | us48576u1060_012524.txt | 0001086364-24-003344 | 005-87705 | 24561129 | 34 | 13465 | |||
| 2024-01-22 | SC 13G/A | Karyopharm_Th_Inc.txt | 0000093751-24-000068 | 005-87705 | 24548056 | 34 | 8462 | |||
| 2024-01-08 | 4 | 4 | 0000950170-24-003177 | 4845 | ||||||
| 2024-01-08 | 8-K | 8-K | 2.02,9.01 | 0001193125-24-003978 | 001-36167 | 24518547 | 34 | 224260 | 1 | 1 |
| 2023-12-12 | 8-K | 8-K | 3.01 | 0001193125-23-293373 | 001-36167 | 231481282 | 34 | 146920 | 1 | 1 |
| 2023-12-08 | 8-K | 8-K | 5.02 | 0001193125-23-291208 | 001-36167 | 231473956 | 34 | 141428 | 1 | 1 |
| 2023-12-05 | 4 | FORM 4 SUBMISSION | 0001209191-23-057465 | 4994 | ||||||
| 2023-11-07 | 4 | FORM 4 SUBMISSION | 0001209191-23-054626 | 4996 | ||||||
| 2023-11-02 | 10-Q | 10-Q | 0000950170-23-057754 | 001-36167 | 231370143 | 34 | 8998859 | 1 | 1 | |
| 2023-11-02 | 8-K | 8-K | 2.02,9.01 | 0001193125-23-268840 | 001-36167 | 231370110 | 34 | 288709 | 1 | 1 |
| 2023-10-05 | 4 | FORM 4 SUBMISSION | 0001209191-23-052215 | 4994 | ||||||
| 2023-09-12 | 4 | 4 | 0000950170-23-047712 | 4780 | ||||||
| 2023-09-06 | 4 | 4 | 0000950170-23-046721 | 6169 | ||||||
| 2023-09-05 | 4 | FORM 4 SUBMISSION | 0001209191-23-048162 | 4993 | ||||||
| 2023-09-05 | 4 | FORM 4 SUBMISSION | 0001209191-23-048161 | 5020 | ||||||
| 2023-09-05 | 4 | FORM 4 SUBMISSION | 0001209191-23-048159 | 5060 | ||||||
| 2023-09-01 | 4 | FORM 4 SUBMISSION | 0001209191-23-047913 | 5420 | ||||||
| 2023-09-01 | 3 | FORM 3 SUBMISSION | 0001209191-23-047912 | 7128 | ||||||
| 2023-09-01 | 8-K | 8-K | 5.02 | 0001193125-23-226903 | 001-36167 | 231230661 | 34 | 147355 | 1 | 1 |
| 2023-08-08 | 4 | FORM 4 SUBMISSION | 0001209191-23-045045 | 4994 | ||||||
| 2023-08-02 | S-8 | S-8 | 0001193125-23-201207 | 333-273593 | 231133882 | 33 | 79001 | |||
| 2023-08-02 | 10-Q | 10-Q | 0000950170-23-036780 | 001-36167 | 231133750 | 34 | 10712026 | 1 | 1 | |
| 2023-08-02 | 8-K | 8-K | 2.02,9.01 | 0001193125-23-201161 | 001-36167 | 231133741 | 34 | 283431 | 1 | 1 |
| 2023-08-01 | 4 | FORM 4 SUBMISSION | 0001209191-23-044040 | 4997 | ||||||
| 2023-07-10 | SC 13G/A | Karyopharm_Thera_Inc.txt | 0000093751-23-000633 | 005-87705 | 231079400 | 34 | 8359 | |||
| 2023-07-06 | 4 | FORM 4 SUBMISSION | 0001209191-23-041635 | 4994 | ||||||
| 2023-06-12 | 4 | FORM 4 SUBMISSION | 0001209191-23-036248 | 5260 | ||||||
| 2023-06-07 | 4 | FORM 4 SUBMISSION | 0001209191-23-035057 | 5438 | ||||||
| 2023-06-05 | 4 | FORM 4 SUBMISSION | 0001209191-23-034262 | 4989 | ||||||
| 2023-05-25 | 4 | FORM 4 SUBMISSION | 0001209191-23-032152 | 5290 | ||||||
| 2023-05-25 | 4 | FORM 4 SUBMISSION | 0001209191-23-032149 | 5308 | ||||||
| 2023-05-25 | 4 | FORM 4 SUBMISSION | 0001209191-23-032146 | 5278 | ||||||
| 2023-05-25 | 4 | FORM 4 SUBMISSION | 0001209191-23-032144 | 5305 | ||||||
| 2023-05-25 | 4 | FORM 4 SUBMISSION | 0001209191-23-032140 | 5264 | ||||||
| 2023-05-25 | 4 | FORM 4 SUBMISSION | 0001209191-23-032138 | 5295 | ||||||
| 2023-05-25 | 4 | FORM 4 SUBMISSION | 0001209191-23-032137 | 5293 | ||||||
| 2023-05-25 | 8-K | 8-K | 5.02,5.07,9.01 | 0001193125-23-154191 | 001-36167 | 23960362 | 34 | 171000 | 1 | 1 |
| 2023-05-05 | EFFECT | xslEFFECTX01/primary_doc.xml | S-3,,2023-05-05 16:30:00 | 9999999995-23-001314 | 333-269846 | 23895718 | 33 | 1715 | ||
| 2023-05-05 | 4 | FORM 4 SUBMISSION | 0000899243-23-012353 | 5437 | ||||||
| 2023-05-04 | 10-Q | 10-Q | 0000950170-23-017483 | 001-36167 | 23886612 | 34 | 8798434 | 1 | 1 | |
| 2023-05-04 | 8-K | 8-K | 2.02,9.01 | 0001193125-23-135082 | 001-36167 | 23886584 | 34 | 266725 | 1 | 1 |
| 2023-05-03 | CORRESP | filename1.htm | 0001193125-23-133252 | 5900 | ||||||
| 2023-04-24 | 4 | FORM 4 SUBMISSION | 0001209191-23-025464 | 6607 | ||||||
| 2023-04-11 | ARS | ARS | 0001193125-23-097204 | 001-36167 | 23812416 | 34 | 2741250 | |||
| 2023-04-11 | DEFA14A | DEFA14A | 0000950170-23-012369 | 001-36167 | 23812405 | 34 | 2092783 | |||
| 2023-04-11 | DEF 14A | DEF 14A | 0000950170-23-012367 | 001-36167 | 23812398 | 34 | 9202823 | 1 | 1 | |
| 2023-04-05 | 4 | FORM 4 SUBMISSION | 0001209191-23-023378 | 4993 | ||||||
| 2023-03-31 | PRE 14A | PRE 14A | 0000950170-23-011381 | 001-36167 | 23787768 | 34 | 6356679 | 1 | 1 | |
| 2023-03-10 | 8-K | 8-K | 7.01 | 0001193125-23-067595 | 001-36167 | 23723670 | 34 | 142500 | 1 | 1 |
| 2023-03-07 | 4 | FORM 4 SUBMISSION | 0001209191-23-016700 | 4826 | ||||||
| 2023-03-02 | 4 | FORM 4 SUBMISSION | 0001209191-23-014873 | 4957 | ||||||
| 2023-03-02 | 4 | FORM 4 SUBMISSION | 0001209191-23-014872 | 4908 | ||||||
| 2023-03-02 | 4 | FORM 4 SUBMISSION | 0001209191-23-014869 | 7040 | ||||||
| 2023-03-02 | 4 | FORM 4 SUBMISSION | 0001209191-23-014865 | 6758 | ||||||
| 2023-03-02 | 4 | FORM 4 SUBMISSION | 0001209191-23-014861 | 7004 | ||||||
| 2023-03-02 | 4 | FORM 4 SUBMISSION | 0001209191-23-014843 | 6731 | ||||||
| 2023-03-02 | 4 | FORM 4 SUBMISSION | 0001209191-23-014838 | 6735 | ||||||
| 2023-03-01 | 4 | FORM 4 SUBMISSION | 0001209191-23-014078 | 4826 | ||||||
| 2023-02-21 | UPLOAD | filename1.pdf | 0000000000-23-001718 | 40258 | ||||||
| 2023-02-17 | 4 | FORM 4 SUBMISSION | 0001209191-23-010509 | 7948 | ||||||
| 2023-02-17 | S-3 | S-3 | 0001193125-23-041600 | 333-269846 | 23640437 | 33 | 1529439 | |||
| 2023-02-17 | S-8 | S-8 | 0001193125-23-041597 | 333-269845 | 23640429 | 33 | 77084 | |||
| 2023-02-17 | 10-K | 10-K | 0000950170-23-003129 | 001-36167 | 23640292 | 34 | 21802335 | 1 | 1 | |
| 2023-02-15 | 8-K | 8-K | 5.02,9.01 | 0001193125-23-040183 | 001-36167 | 23635324 | 34 | 207997 | 1 | 1 |
| 2023-02-15 | 8-K | 8-K | 2.02,9.01 | 0001193125-23-039757 | 001-36167 | 23633635 | 34 | 279229 | 1 | 1 |
| 2023-02-14 | SC 13G/A | karypharmv2.txt | 0001306923-23-000006 | 005-87705 | 23629777 | 34 | 271759 | |||
| 2023-02-14 | SC 13G/A | formsc13ga.htm | 0001493152-23-004859 | 005-87705 | 23628884 | 34 | 89490 | |||
| 2023-02-14 | SC 13G/A | AMENDMENT NO. 8 TO SCHEDULE 13G | 0001213900-23-011440 | 005-87705 | 23628108 | 34 | 212600 | |||
| 2023-02-14 | SC 13G/A | d9881732_13g-a.htm | 0000919574-23-001620 | 005-87705 | 23627980 | 34 | 181492 | |||
| 2023-02-10 | SC 13G | SC 13G | 0001104659-23-018475 | 005-87705 | 23611634 | 34 | 83378 | |||
| 2023-02-08 | 4 | FORM 4 SUBMISSION | 0001209191-23-007775 | 4824 | ||||||
| 2023-02-08 | 4 | FORM 4 SUBMISSION | 0001209191-23-007772 | 4827 | ||||||
| 2023-02-02 | SC 13G/A | Karyopharm_Therapeutics_Inc.txt | 0000093751-23-000090 | 005-87705 | 23579711 | 34 | 10364 | |||
| 2023-01-26 | SC 13G/A | us48576u1060_012623.txt | 0001306550-23-004203 | 005-87705 | 23554461 | 34 | 13403 | |||
| 2023-01-20 | SC 13G | us48576u1060_012023.txt | 0001306550-23-001542 | 005-87705 | 23541922 | 34 | 13370 | |||
| 2023-01-09 | 8-K | 8-K | 2.02,9.01 | 0001193125-23-004183 | 001-36167 | 23516688 | 34 | 212315 | 1 | 1 |
| 2023-01-05 | 4 | FORM 4 SUBMISSION | 0001209191-23-002052 | 4827 | ||||||
| 2023-01-03 | EFFECT | xslEFFECTX01/primary_doc.xml | S-3,,2023-01-03 16:30:00 | 9999999995-23-000026 | 333-268991 | 23504255 | 33 | 1715 | ||
| 2022-12-29 | CORRESP | filename1.htm | 0001193125-22-314423 | 6635 | ||||||
| 2022-12-28 | UPLOAD | filename1.pdf | 0000000000-22-013952 | 40221 | ||||||
| 2022-12-23 | S-3 | S-3 | 0001193125-22-311793 | 333-268991 | 221485529 | 33 | 1066612 | |||
| 2022-12-14 | 8-K | 8-K | 8.01 | 0001193125-22-303934 | 001-36167 | 221460598 | 34 | 150967 | 1 | 1 |
| 2022-12-08 | D | xslFormDX01/primary_doc.xml | 06b | 0001503802-22-000001 | 021-466961 | 221452478 | 33 | 21211 | ||
| 2022-12-08 | SC 13G | d9881732_13g.htm | 0000919574-22-007017 | 005-87705 | 221451623 | 34 | 184312 | |||
| 2022-12-06 | 4 | FORM 4 SUBMISSION | 0001209191-22-060041 | 4828 | ||||||
| 2022-12-05 | 8-K | 8-K | 1.01,3.02,8.01,9.01 | 0001193125-22-298052 | 001-36167 | 221443841 | 34 | 703834 | 1 | 1 |
| 2022-12-02 | 8-K | 8-K | 5.03,9.01 | 0001193125-22-297530 | 001-36167 | 221441961 | 34 | 314777 | 1 | 1 |
| 2022-11-08 | 4 | FORM 4 SUBMISSION | 0001209191-22-056152 | 4828 | ||||||
| 2022-11-03 | 10-Q | 10-Q | 0000950170-22-021917 | 001-36167 | 221358477 | 34 | 9862941 | 1 | 1 | |
| 2022-11-03 | 8-K | 8-K | 2.02,9.01 | 0001193125-22-276891 | 001-36167 | 221358095 | 34 | 265800 | 1 | 1 |
| 2022-10-05 | 4 | FORM 4 SUBMISSION | 0001209191-22-052726 | 4828 | ||||||
| 2022-09-09 | 4 | FORM 4 SUBMISSION | 0001209191-22-049255 | 6390 | ||||||
| 2022-09-01 | 4 | FORM 4 SUBMISSION | 0001209191-22-048397 | 7470 | ||||||
| 2022-09-01 | 4 | FORM 4 SUBMISSION | 0001209191-22-048396 | 7442 | ||||||
| 2022-09-01 | 4 | FORM 4 SUBMISSION | 0001209191-22-048395 | 7483 | ||||||
| 2022-09-01 | 4 | FORM 4 SUBMISSION | 0001209191-22-048394 | 7415 | ||||||
| 2022-08-19 | 3 | FORM 3 SUBMISSION | 0001209191-22-046824 | 11016 | ||||||
| 2022-08-15 | 4 | FORM 4 SUBMISSION | 0001209191-22-045718 | 6950 | ||||||
| 2022-08-05 | 4 | FORM 4 SUBMISSION | 0001209191-22-044561 | 4828 | ||||||
| 2022-08-04 | 10-Q | 10-Q | 0000950170-22-014788 | 001-36167 | 221137093 | 34 | 10246569 | 1 | 1 | |
| 2022-08-04 | 8-K | 8-K | 2.02,9.01 | 0001193125-22-211832 | 001-36167 | 221134727 | 34 | 278422 | 1 | 1 |
| 2022-07-28 | 8-K | 8-K | 5.02 | 0001193125-22-204195 | 001-36167 | 221112873 | 34 | 145260 | 1 | 1 |
| 2022-07-11 | 4 | FORM 4 SUBMISSION | 0001209191-22-041774 | 4830 | ||||||
| 2022-06-15 | 8-K | 8-K | 1.02 | 0001193125-22-174750 | 001-36167 | 221017828 | 34 | 146473 | 1 | 1 |
| 2022-06-14 | 4 | FORM 4 SUBMISSION | 0001209191-22-036812 | 6442 | ||||||
| 2022-06-10 | 4 | FORM 4 SUBMISSION | 0000899243-22-021957 | 15098 | ||||||
| 2022-06-08 | 4 | FORM 4 SUBMISSION | 0000899243-22-021477 | 4830 | ||||||
| 2022-06-06 | 4 | FORM 4 SUBMISSION | 0000899243-22-021234 | 6378 | ||||||
| 2022-06-03 | S-8 | S-8 | 0001193125-22-166718 | 333-265386 | 22992907 | 33 | 116039 | |||
| 2022-05-23 | 8-K | 8-K | 5.02,5.07,9.01 | 0001193125-22-157447 | 001-36167 | 22951609 | 34 | 160830 | 1 | 1 |
| 2022-05-20 | 4 | FORM 4 SUBMISSION | 0001209191-22-030986 | 5347 | ||||||
| 2022-05-20 | 4 | FORM 4 SUBMISSION | 0001209191-22-030983 | 5371 | ||||||
| 2022-05-20 | 4 | FORM 4 SUBMISSION | 0001209191-22-030978 | 5335 | ||||||
| 2022-05-20 | 4 | FORM 4 SUBMISSION | 0001209191-22-030972 | 5362 | ||||||
| 2022-05-20 | 4 | FORM 4 SUBMISSION | 0001209191-22-030970 | 5321 | ||||||
| 2022-05-20 | 4 | FORM 4 SUBMISSION | 0001209191-22-030956 | 5352 | ||||||
| 2022-05-20 | 4 | FORM 4 SUBMISSION | 0001209191-22-030953 | 5350 | ||||||
| 2022-05-12 | DEFA14A | DEFA14A | 0001193125-22-148265 | 001-36167 | 22916337 | 34 | 41616 | |||
| 2022-05-09 | SC 13G | formsc13g.htm | 0001493152-22-012564 | 005-87705 | 22905492 | 34 | 99375 | |||
| 2022-05-05 | 4 | FORM 4 SUBMISSION | 0001209191-22-027344 | 6393 | ||||||
| 2022-05-05 | 10-Q | 10-Q | 0000950170-22-007564 | 001-36167 | 22894091 | 34 | 8784461 | 1 | 1 | |
| 2022-05-05 | 8-K | 8-K | 2.02,9.01 | 0001193125-22-141284 | 001-36167 | 22894009 | 34 | 254996 | 1 | 1 |
| 2022-05-02 | 4 | FORM 4 SUBMISSION | 0001209191-22-026425 | 7468 | ||||||
| 2022-04-29 | 3 | FORM 3 SUBMISSION | 0001209191-22-026106 | 7300 | ||||||
| 2022-04-08 | DEFA14A | DEFA14A | 0001193125-22-099758 | 001-36167 | 22815504 | 34 | 143102 | |||
| 2022-04-08 | DEF 14A | DEF 14A | 0000950170-22-005492 | 001-36167 | 22815434 | 34 | 4464818 | |||
| 2022-03-31 | 4 | FORM 4 SUBMISSION | 0001209191-22-021755 | 8154 | ||||||
| 2022-03-29 | 8-K | 8-K | 5.02,9.01 | 0001193125-22-087458 | 001-36167 | 22777476 | 34 | 350297 | 1 | 1 |
| 2022-03-28 | 8-K | 8-K | 5.02 | 0001193125-22-086854 | 001-36167 | 22776440 | 34 | 141748 | 1 | 1 |
| 2022-03-02 | 4 | FORM 4 SUBMISSION | 0001209191-22-014629 | 9750 |
One latest value per concept from companyfacts (321 concepts). Full history stays in the JSON.
| Taxonomy | Tag | Label | Unit | Value | Start | End | FY | FP | Form | Filed | Accn |
|---|---|---|---|---|---|---|---|---|---|---|---|
| dei | EntityCommonStockSharesOutstanding | Entity Common Stock, Shares Outstanding | shares | 22.68M | 2026-08-06 | 2026 | Q2 | 10-Q | 2026-08-13 | 0001193125-26-347906 | |
| dei | EntityPublicFloat | Entity Public Float | USD | 37.00M | 2025-06-30 | 2025 | FY | 10-K | 2026-02-13 | 0001193125-26-049397 | |
| ecd | NonPeoNeoAvgCompActuallyPaidAmt | NonPeoNeoAvgCompActuallyPaidAmt | USD | 1.62M | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-13 | 0001503802-26-000023 | ||
| ecd | NonPeoNeoAvgTotalCompAmt | NonPeoNeoAvgTotalCompAmt | USD | 1.71M | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-13 | 0001503802-26-000023 | ||
| ecd | PeoActuallyPaidCompAmt | PeoActuallyPaidCompAmt | USD | 2.12M | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-13 | 0001503802-26-000023 | ||
| ecd | PeoTotalCompAmt | PeoTotalCompAmt | USD | 2.32M | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-13 | 0001503802-26-000023 | ||
| ecd | TotalShareholderRtnAmt | TotalShareholderRtnAmt | USD | 14.43 | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-13 | 0001503802-26-000023 | ||
| ffd | NetFeeAmt | NetFeeAmt | USD | 16,604.15 | 2026-05-04 | S-3 | 2026-05-04 | 0001193125-26-204130 | |||
| ffd | TtlFeeAmt | TtlFeeAmt | USD | 16,604.15 | 2026-05-04 | S-3 | 2026-05-04 | 0001193125-26-204130 | |||
| ffd | TtlOfferingAmt | TtlOfferingAmt | USD | 400.00M | 2026-05-04 | S-3 | 2026-05-04 | 0001193125-26-204130 | |||
| ffd | TtlOffsetAmt | TtlOffsetAmt | USD | 0 | 2026-05-04 | S-3 | 2026-05-04 | 0001193125-26-204130 | |||
| ffd | TtlPrevslyPdAmt | TtlPrevslyPdAmt | USD | 0 | 2026-05-04 | S-3 | 2026-05-04 | 0001193125-26-204130 | |||
| us-gaap | AccountsPayableCurrent | Accounts Payable, Current | USD | 7.66M | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-13 | 0001193125-26-347906 | |
| us-gaap | AccretionAmortizationOfDiscountsAndPremiumsInvestments | Accretion (Amortization) of Discounts and Premiums, Investments | USD | 88,000 | 2026-01-01 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-13 | 0001193125-26-347906 |
| us-gaap | AccruedLiabilitiesCurrent | Accrued Liabilities, Current | USD | 78.80M | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-13 | 0001193125-26-347906 | |
| us-gaap | AccruedProfessionalFeesCurrent | Accrued Professional Fees, Current | USD | 5.96M | 2021-12-31 | 2021 | FY | 10-K | 2022-03-01 | 0000950170-22-002548 | |
| us-gaap | AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment | Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment | USD | 5.51M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-13 | 0001193125-26-049397 | |
| us-gaap | AccumulatedOtherComprehensiveIncomeLossNetOfTax | Accumulated Other Comprehensive Income (Loss), Net of Tax | USD | 41,000 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-13 | 0001193125-26-347906 | |
| us-gaap | AdditionalPaidInCapital | Additional Paid in Capital | USD | 345.17M | 2014-12-31 | 2014 | FY | 10-K | 2015-03-13 | 0001193125-15-091264 | |
| us-gaap | AdditionalPaidInCapitalCommonStock | Additional Paid in Capital, Common Stock | USD | 1.52B | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-13 | 0001193125-26-347906 | |
| us-gaap | AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation | Share-based Payment Arrangement, Decrease for Tax Withholding Obligation | USD | 39,000 | 2016-01-01 | 2016-12-31 | 2018 | FY | 10-K | 2019-02-28 | 0001193125-19-057610 |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt | Adjustments to Additional Paid in Capital, Equity Component of Convertible Debt | USD | 67.85M | 2018-01-01 | 2018-12-31 | 2020 | FY | 10-K | 2021-02-24 | 0001193125-21-054811 |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue | APIC, Share-based Payment Arrangement, Increase for Cost Recognition | USD | 4.94M | 2026-01-01 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-13 | 0001193125-26-347906 |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition | APIC, Share-based Payment Arrangement, Restricted Stock Unit, Increase for Cost Recognition | USD | 12,000 | 2011-01-01 | 2011-12-31 | 2013 | FY | 10-K | 2014-03-21 | 0001047469-14-002800 |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalWarrantIssued | Adjustments to Additional Paid in Capital, Warrant Issued | USD | 239,000 | 2023-01-01 | 2023-12-31 | 2025 | FY | 10-K | 2026-02-13 | 0001193125-26-049397 |
| us-gaap | AllocatedShareBasedCompensationExpense | Share-based Payment Arrangement, Expense | USD | 4.94M | 2026-01-01 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-13 | 0001193125-26-347906 |
| us-gaap | AllowanceForDoubtfulAccountsReceivable | Accounts Receivable, Allowance for Credit Loss | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-13 | 0001193125-26-049397 | |
| us-gaap | AllowanceForDoubtfulAccountsReceivableCurrent | Accounts Receivable, Allowance for Credit Loss, Current | USD | 0 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-13 | 0001193125-26-347906 | |
| us-gaap | AllowanceForDoubtfulAccountsReceivableWriteOffs | Accounts Receivable, Allowance for Credit Loss, Writeoff | USD | 0 | 2026-01-01 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-13 | 0001193125-26-347906 |
| us-gaap | AmortizationOfFinancingCostsAndDiscounts | Amortization of Debt Issuance Costs and Discounts | USD | 4.92M | 2026-01-01 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-13 | 0001193125-26-347906 |
| us-gaap | AreaOfRealEstateProperty | Area of Real Estate Property | sqft | 3,681 | 2014-11-30 | 2018 | Q1 | 10-Q | 2018-05-10 | 0001193125-18-159200 | |
| us-gaap | Assets | Assets | USD | 111.32M | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-13 | 0001193125-26-347906 | |
| us-gaap | AssetsCurrent | Assets, Current | USD | 106.38M | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-13 | 0001193125-26-347906 | |
| us-gaap | AssetsFairValueDisclosure | Assets, Fair Value Disclosure | USD | 42.73M | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-13 | 0001193125-26-347906 | |
| us-gaap | AvailableForSaleDebtSecuritiesAmortizedCostBasis | Debt Securities, Available-for-sale, Amortized Cost | USD | 46.17M | 2024-12-31 | 2025 | FY | 10-K | 2026-02-13 | 0001193125-26-049397 | |
| us-gaap | AvailableForSaleDebtSecuritiesGrossUnrealizedGain | Debt Securities, Available-for-sale, Unrealized Gain | USD | 68,000 | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-02-13 | 0001193125-26-049397 |
| us-gaap | AvailableForSaleDebtSecuritiesGrossUnrealizedLoss | Debt Securities, Available-for-sale, Unrealized Loss | USD | 2,000 | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-02-13 | 0001193125-26-049397 |
| us-gaap | AvailableForSaleSecurities | Available-for-sale Securities | USD | 179.61M | 2019-09-30 | 2019 | Q3 | 10-Q | 2019-11-04 | 0001193125-19-282510 | |
| us-gaap | AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax | Available-for-sale Securities, Accumulated Gross Unrealized Gain, before Tax | USD | 49,000 | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-11-03 | 0000950170-21-002729 | |
| us-gaap | AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax | Available-for-sale Securities, Accumulated Gross Unrealized Loss, before Tax | USD | 7,000 | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-11-03 | 0000950170-21-002729 | |
| us-gaap | AvailableForSaleSecuritiesAmortizedCost | Available-for-sale Securities, Amortized Cost Basis | USD | 68.78M | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-11-03 | 0000950170-21-002729 | |
| us-gaap | AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue | Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value | USD | 96.62M | 2017-12-31 | 2017 | FY | 10-K | 2018-03-15 | 0001193125-18-084024 | |
| us-gaap | AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue | Available-for-sale Securities, Continuous Unrealized Loss Position, Less than Twelve Months, Fair Value | USD | 63.80M | 2019-12-31 | 2019 | FY | 10-K | 2020-02-26 | 0001193125-20-049115 | |
| us-gaap | AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue | Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One | USD | 55.12M | 2014-12-31 | 2014 | FY | 10-K | 2015-03-13 | 0001193125-15-091264 | |
| us-gaap | AvailableForSaleSecuritiesDebtSecurities | Debt Securities, Available-for-sale | USD | 0 | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-05-14 | 0001193125-26-222827 | |
| us-gaap | AvailableForSaleSecuritiesDebtSecuritiesCurrent | Debt Securities, Available-for-sale, Current | USD | 10.13M | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-13 | 0001193125-26-347906 | |
| us-gaap | AvailableForSaleSecuritiesDebtSecuritiesNoncurrent | Debt Securities, Available-for-sale, Noncurrent | USD | 24.21M | 2020-12-31 | 2021 | FY | 10-K | 2022-03-01 | 0000950170-22-002548 | |
| us-gaap | AvailableforsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsGreaterThanOrEqualToOneYear | Available-for-sale, Securities in Unrealized Loss Positions, Qualitative Disclosure, Number of Positions, Greater than or Equal to One Year | Securities | 0 | 2018-03-31 | 2018 | Q1 | 10-Q | 2018-05-10 | 0001193125-18-159200 | |
| us-gaap | AvailableForSaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsLessThanOneYear | Available-for-sale, Securities in Unrealized Loss Positions, Qualitative Disclosure, Number of Positions, Less than One Year | Security | 13 | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-11-03 | 0000950170-21-002729 | |
| us-gaap | CapitalExpendituresIncurredButNotYetPaid | Capital Expenditures Incurred but Not yet Paid | USD | 56,000 | 2018-01-01 | 2018-03-31 | 2018 | Q1 | 10-Q | 2018-05-10 | 0001193125-18-159200 |
| us-gaap | CapitalLeaseObligationsIncurred | Lease Obligation Incurred | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-13 | 0001193125-26-049397 |
| us-gaap | CashAndCashEquivalentsAtCarryingValue | Cash and Cash Equivalents, at Carrying Value | USD | 54.98M | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-13 | 0001193125-26-347906 | |
| us-gaap | CashAndCashEquivalentsFairValueDisclosure | Cash and Cash Equivalents, Fair Value Disclosure | USD | 129.21M | 2014-12-31 | 2014 | FY | 10-K | 2015-03-13 | 0001193125-15-091264 | |
| us-gaap | CashAndCashEquivalentsPeriodIncreaseDecrease | Cash and Cash Equivalents, Period Increase (Decrease) | USD | 19.33M | 2017-01-01 | 2017-12-31 | 2017 | FY | 10-K | 2018-03-15 | 0001193125-18-084024 |
| us-gaap | CashCashEquivalentsAndShortTermInvestments | Cash, Cash Equivalents, and Short-term Investments | USD | 65.10M | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-13 | 0001193125-26-347906 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | USD | 55.30M | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-13 | 0001193125-26-347906 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | USD | -5.59M | 2026-01-01 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-13 | 0001193125-26-347906 |
| us-gaap | ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 | Class of Warrant or Right, Exercise Price of Warrants or Rights | USD/shares | 0 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-13 | 0001193125-26-347906 | |
| us-gaap | ClassOfWarrantOrRightOutstanding | Class of Warrant or Right, Outstanding | shares | 18.05M | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-13 | 0001193125-26-347906 | |
| us-gaap | CommonStockCapitalSharesReservedForFutureIssuance | Common Stock, Capital Shares Reserved for Future Issuance | shares | 474,615 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-13 | 0001193125-26-347906 | |
| us-gaap | CommonStockParOrStatedValuePerShare | Common Stock, Par or Stated Value Per Share | USD/shares | 0 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-13 | 0001193125-26-347906 | |
| us-gaap | CommonStockSharesAuthorized | Common Stock, Shares Authorized | shares | 106.00M | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-13 | 0001193125-26-347906 | |
| us-gaap | CommonStockSharesIssued | Common Stock, Shares, Issued | shares | 22.68M | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-13 | 0001193125-26-347906 | |
| us-gaap | CommonStockSharesOutstanding | Common Stock, Shares, Outstanding | shares | 22.68M | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-13 | 0001193125-26-347906 | |
| us-gaap | CommonStockValue | Common Stock, Value, Issued | USD | 14,000 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-13 | 0001193125-26-347906 | |
| us-gaap | ComprehensiveIncomeNetOfTax | Comprehensive Income (Loss), Net of Tax, Attributable to Parent | USD | -89.44M | 2026-01-01 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-13 | 0001193125-26-347906 |
| us-gaap | ContractWithCustomerLiabilityNoncurrent | Contract with Customer, Liability, Noncurrent | USD | 1.30M | 2020-05-31 | 2022 | FY | 10-K | 2023-02-17 | 0000950170-23-003129 | |
| us-gaap | ContractWithCustomerLiabilityRevenueRecognized | Contract with Customer, Liability, Revenue Recognized | USD | 5.80M | 2017-04-28 | 2019 | Q3 | 10-Q | 2019-11-04 | 0001193125-19-282510 | |
| us-gaap | ConversionOfStockAmountConverted1 | Conversion of Stock, Amount Converted | USD | 99.69M | 2013-01-01 | 2013-12-31 | 2015 | FY | 10-K | 2016-03-15 | 0001193125-16-505181 |
| us-gaap | ConvertibleDebtFairValueDisclosures | Convertible Debt, Fair Value Disclosures | USD | 104.70M | 2020-12-31 | 2020 | FY | 10-K | 2021-02-24 | 0001193125-21-054811 | |
| us-gaap | ConvertibleLongTermNotesPayable | Convertible Notes Payable, Noncurrent | USD | 0 | 2024-12-31 | 2024 | FY | 10-K | 2025-02-19 | 0000950170-25-022765 | |
| us-gaap | CostOfGoodsAndServicesSold | Cost of Goods and Services Sold | USD | 1.01M | 2019-01-01 | 2019-09-30 | 2019 | Q3 | 10-Q | 2019-11-04 | 0001193125-19-282510 |
| us-gaap | DebtConversionConvertedInstrumentAmount1 | Debt Conversion, Converted Instrument, Amount | USD | 750,000 | 2008-12-22 | 2014-03-31 | 2014 | Q1 | 10-Q | 2014-05-08 | 0001104659-14-036479 |
| us-gaap | DebtInstrumentCarryingAmount | Long-term Debt, Gross | USD | 193.20M | 2021-12-31 | 2021 | FY | 10-K | 2022-03-01 | 0000950170-22-002548 | |
| us-gaap | DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent | Debt Instrument, Convertible, Carrying Amount of Equity Component | USD | 67.90M | 2020-12-31 | 2020 | FY | 10-K | 2021-02-24 | 0001193125-21-054811 | |
| us-gaap | DebtInstrumentConvertibleConversionPrice1 | Debt Instrument, Convertible, Conversion Price | USD/shares | 1 | 2018-10-16 | 2020 | Q3 | 10-Q | 2020-11-02 | 0001564590-20-049664 | |
| us-gaap | DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal | Debt Instrument, Convertible, If-converted Value in Excess of Principal | USD | 0 | 2020-01-01 | 2020-09-30 | 2020 | Q3 | 10-Q | 2020-11-02 | 0001564590-20-049664 |
| us-gaap | DebtInstrumentConvertibleThresholdConsecutiveTradingDays1 | Debt Instrument, Convertible, Threshold Consecutive Trading Days | Days | 5 | 2025-01-01 | 2025-03-31 | 2025 | Q1 | 10-Q | 2025-05-12 | 0000950170-25-069231 |
| us-gaap | DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction | Debt Issuance Costs Incurred During Noncash or Partial Noncash Transaction | USD | 22,000 | 2022-01-01 | 2022-03-31 | 2022 | Q1 | 10-Q | 2022-05-05 | 0000950170-22-007564 |
| us-gaap | DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger | Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer | USD | 0 | 2024-12-31 | 2025 | FY | 10-K | 2026-02-13 | 0001193125-26-049397 | |
| us-gaap | DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss | Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss | USD | 0 | 2024-12-31 | 2025 | FY | 10-K | 2026-02-13 | 0001193125-26-049397 | |
| us-gaap | DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months | Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months | USD | 5.63M | 2024-12-31 | 2025 | FY | 10-K | 2026-02-13 | 0001193125-26-049397 | |
| us-gaap | DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss | Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss | USD | 2,000 | 2024-12-31 | 2025 | FY | 10-K | 2026-02-13 | 0001193125-26-049397 | |
| us-gaap | DebtSecuritiesAvailableForSaleUnrealizedLossPosition | Debt Securities, Available-for-sale, Unrealized Loss Position | USD | 5.63M | 2024-12-31 | 2025 | FY | 10-K | 2026-02-13 | 0001193125-26-049397 | |
| us-gaap | DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss | Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss | USD | 2,000 | 2024-12-31 | 2025 | FY | 10-K | 2026-02-13 | 0001193125-26-049397 | |
| us-gaap | DeferredIncomeTaxExpenseBenefit | Deferred Income Tax Expense (Benefit) | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-13 | 0001193125-26-049397 |
| us-gaap | DeferredIncomeTaxLiabilities | Deferred Tax Liabilities, Gross | USD | 9.04M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-13 | 0001193125-26-049397 | |
| us-gaap | DeferredRentCreditCurrent | Deferred Rent Credit, Current | USD | 390,000 | 2018-12-31 | 2019 | FY | 10-K | 2020-02-26 | 0001193125-20-049115 | |
| us-gaap | DeferredRentCreditNoncurrent | Deferred Rent Credit, Noncurrent | USD | 3.92M | 2018-12-31 | 2019 | FY | 10-K | 2020-02-26 | 0001193125-20-049115 | |
| us-gaap | DeferredRevenue | Deferred Revenue | USD | 297,000 | 2020-12-31 | 2020 | FY | 10-K | 2021-02-24 | 0001193125-21-054811 | |
| us-gaap | DeferredRevenueCurrent | Deferred Revenue, Current | USD | 297,000 | 2020-12-31 | 2021 | FY | 10-K | 2022-03-01 | 0000950170-22-002548 | |
| us-gaap | DeferredRevenueNoncurrent | Deferred Revenue, Noncurrent | USD | 0 | 2020-12-31 | 2020 | FY | 10-K | 2021-02-24 | 0001193125-21-054811 | |
| us-gaap | DeferredTaxAssetsDeferredIncome | Deferred Tax Assets, Deferred Income | USD | 0 | 2020-12-31 | 2020 | FY | 10-K | 2021-02-24 | 0001193125-21-054811 | |
| us-gaap | DeferredTaxAssetsGross | Deferred Tax Assets, Gross | USD | 9.04M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-13 | 0001193125-26-049397 | |
| us-gaap | DeferredTaxAssetsInProcessResearchAndDevelopment | Deferred Tax Assets, in Process Research and Development | USD | 63.12M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-13 | 0001193125-26-049397 | |
| us-gaap | DeferredTaxAssetsLiabilitiesNet | Deferred Tax Assets, Net | USD | 0 | 2014-12-31 | 2014 | FY | 10-K | 2015-03-13 | 0001193125-15-091264 | |
| us-gaap | DeferredTaxAssetsNet | Deferred Tax Assets, Net of Valuation Allowance | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-13 | 0001193125-26-049397 | |
| us-gaap | DeferredTaxAssetsOperatingLossCarryforwardsForeign | Deferred Tax Assets, Operating Loss Carryforwards, Foreign | USD | 0 | 2020-12-31 | 2020 | FY | 10-K | 2021-02-24 | 0001193125-21-054811 | |
| us-gaap | DeferredTaxAssetsTaxCreditCarryforwardsResearch | Deferred Tax Assets, Tax Credit Carryforwards, Research | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-13 | 0001193125-26-049397 | |
| us-gaap | DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost | Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost | USD | 2.83M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-13 | 0001193125-26-049397 | |
| us-gaap | DeferredTaxAssetsValuationAllowance | Deferred Tax Assets, Valuation Allowance | USD | 312.80M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-13 | 0001193125-26-049397 | |
| us-gaap | DeferredTaxExpenseFromStockOptionsExercised | Deferred Tax Expense from Stock Options Exercised | USD | 4.70M | 2016-01-01 | 2016-12-31 | 2016 | FY | 10-K | 2017-03-16 | 0001193125-17-084396 |
| us-gaap | DefinedContributionPlanEmployerDiscretionaryContributionAmount | Defined Contribution Plan, Employer Discretionary Contribution Amount | USD | 2.30M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-13 | 0001193125-26-049397 |
| us-gaap | DefinedContributionPlanEmployerMatchingContributionPercent | Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay | pure | 0.04 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-13 | 0001193125-26-049397 |
| us-gaap | Depreciation | Depreciation | USD | 9,000 | 2026-01-01 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-13 | 0001193125-26-347906 |
| us-gaap | DepreciationAndAmortization | Depreciation, Depletion and Amortization, Nonproduction | USD | 715,000 | 2020-01-01 | 2020-09-30 | 2020 | Q3 | 10-Q | 2020-11-02 | 0001564590-20-049664 |
| us-gaap | DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage | Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) | USD | 112.42M | 2014-09-30 | 2014 | Q3 | 10-Q | 2014-11-10 | 0001104659-14-078971 | |
| us-gaap | DueToRelatedPartiesCurrent | Due to Related Parties, Current | USD | 0 | 2013-12-31 | 2013 | FY | 10-K | 2014-03-21 | 0001047469-14-002800 | |
| us-gaap | EarningsPerShareBasic | Earnings Per Share, Basic | USD/shares | -3.51 | 2026-01-01 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-13 | 0001193125-26-347906 |
| us-gaap | EarningsPerShareBasicAndDiluted | Earnings Per Share, Basic and Diluted | USD/shares | -0.53 | 2022-01-01 | 2022-03-31 | 2022 | Q1 | 10-Q | 2022-05-05 | 0000950170-22-007564 |
| us-gaap | EarningsPerShareDiluted | Earnings Per Share, Diluted | USD/shares | -3.51 | 2026-01-01 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-13 | 0001193125-26-347906 |
| us-gaap | EffectiveIncomeTaxRateContinuingOperations | Effective Income Tax Rate Reconciliation, Percent | pure | 0.001 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-13 | 0001193125-26-049397 |
| us-gaap | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent | pure | 0.21 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-13 | 0001193125-26-049397 |
| us-gaap | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent | pure | 0.537 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-13 | 0001193125-26-049397 |
| us-gaap | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent | pure | 0 | 2020-01-01 | 2020-12-31 | 2020 | FY | 10-K | 2021-02-24 | 0001193125-21-054811 |
| us-gaap | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent | pure | -0.004 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-13 | 0001193125-26-049397 |
| us-gaap | EffectiveIncomeTaxRateReconciliationNondeductibleExpense | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent | pure | -0.046 | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-02-13 | 0001193125-26-049397 |
| us-gaap | EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent | pure | -0.026 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-13 | 0001193125-26-049397 |
| us-gaap | EffectiveIncomeTaxRateReconciliationOtherAdjustments | Effective Income Tax Rate Reconciliation, Other Adjustments, Percent | pure | 0.001 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-13 | 0001193125-26-049397 |
| us-gaap | EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes | Effective Income Tax Rate Reconciliation, Prior Year Income Taxes, Percent | pure | 0.002 | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-02-13 | 0001193125-26-049397 |
| us-gaap | EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent | Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Percent | pure | -0.053 | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-02-13 | 0001193125-26-049397 |
| us-gaap | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent | pure | 0.039 | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-02-13 | 0001193125-26-049397 |
| us-gaap | EffectiveIncomeTaxRateReconciliationTaxCreditsResearch | Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent | pure | 0.139 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-13 | 0001193125-26-049397 |
| us-gaap | EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations | Effect of Exchange Rate on Cash and Cash Equivalents, Continuing Operations | USD | 200,000 | 2017-01-01 | 2017-12-31 | 2017 | FY | 10-K | 2018-03-15 | 0001193125-18-084024 |
| us-gaap | EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | USD | -2,000 | 2026-01-01 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-13 | 0001193125-26-347906 |
| us-gaap | EffectOfExchangeRateOnCashContinuingOperations | Effect of Exchange Rate on Cash, Continuing Operations | USD | -11,000 | 2015-01-01 | 2015-03-31 | 2015 | Q1 | 10-Q | 2015-05-11 | 0001193125-15-181874 |
| us-gaap | EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability | Embedded Derivative, Fair Value of Embedded Derivative Liability | USD | 2.80M | 2024-03-31 | 2024 | Q1 | 10-Q | 2024-05-08 | 0000950170-24-055672 | |
| us-gaap | EmbeddedDerivativeFairValueOfEmbeddedDerivativeNet | Embedded Derivative, Fair Value of Embedded Derivative, Net | USD | 1.80M | 2020-12-31 | 2020 | FY | 10-K | 2021-02-24 | 0001193125-21-054811 | |
| us-gaap | EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet | Embedded Derivative, Gain (Loss) on Embedded Derivative, Net | USD | -15.55M | 2026-01-01 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-13 | 0001193125-26-347906 |
| us-gaap | EmployeeRelatedLiabilitiesCurrent | Employee-related Liabilities, Current | USD | 4.38M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-13 | 0001193125-26-049397 | |
| us-gaap | FederalIncomeTaxExpenseBenefitContinuingOperations | Federal Income Tax Expense (Benefit), Continuing Operations | USD | -96.68M | 2015-01-01 | 2015-12-31 | 2015 | FY | 10-K | 2016-03-15 | 0001193125-16-505181 |
| us-gaap | ForeignCurrencyTransactionGainLossBeforeTax | Foreign Currency Transaction Gain (Loss), before Tax | USD | 300,000 | 2020-01-01 | 2020-12-31 | 2020 | FY | 10-K | 2021-02-24 | 0001193125-21-054811 |
| us-gaap | ForeignIncomeTaxExpenseBenefitContinuingOperations | Foreign Income Tax Expense (Benefit), Continuing Operations | USD | -21.41M | 2015-01-01 | 2015-12-31 | 2015 | FY | 10-K | 2016-03-15 | 0001193125-16-505181 |
| us-gaap | GainLossOnSaleOfPropertyPlantEquipment | Gain (Loss) on Disposition of Property Plant Equipment | USD | -50,000 | 2014-01-01 | 2014-12-31 | 2016 | FY | 10-K | 2017-03-16 | 0001193125-17-084396 |
| us-gaap | GainsLossesOnExtinguishmentOfDebt | Gain (Loss) on Extinguishment of Debt | USD | -62.37M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-13 | 0001193125-26-049397 |
| us-gaap | GeneralAndAdministrativeExpense | General and Administrative Expense | USD | 51.77M | 2019-01-01 | 2019-06-30 | 2019 | Q2 | 10-Q | 2019-08-07 | 0001193125-19-215344 |
| us-gaap | IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic | Income (Loss) from Continuing Operations before Income Taxes, Domestic | USD | -192.38M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-13 | 0001193125-26-049397 |
| us-gaap | IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | USD | -89.41M | 2026-01-01 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-13 | 0001193125-26-347906 |
| us-gaap | IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign | Income (Loss) from Continuing Operations before Income Taxes, Foreign | USD | -3.61M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-13 | 0001193125-26-049397 |
| us-gaap | IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments | Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest | USD | -195.96M | 2020-01-01 | 2020-12-31 | 2020 | FY | 10-K | 2021-02-24 | 0001193125-21-054811 |
| us-gaap | IncomeTaxExpenseBenefit | Income Tax Expense (Benefit) | USD | 1,000 | 2026-01-01 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-13 | 0001193125-26-347906 |
| us-gaap | IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance | Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount | USD | -105.19M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-13 | 0001193125-26-049397 |
| us-gaap | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount | USD | 840,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-13 | 0001193125-26-049397 |
| us-gaap | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount | USD | -41.16M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-13 | 0001193125-26-049397 |
| us-gaap | IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount | USD | 5.08M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-13 | 0001193125-26-049397 |
| us-gaap | IncomeTaxReconciliationOtherAdjustments | Effective Income Tax Rate Reconciliation, Other Adjustments, Amount | USD | -157,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-13 | 0001193125-26-049397 |
| us-gaap | IncomeTaxReconciliationTaxCreditsResearch | Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount | USD | -27.25M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-13 | 0001193125-26-049397 |
| us-gaap | IncreaseDecreaseInAccountsPayable | Increase (Decrease) in Accounts Payable | USD | 3.66M | 2026-01-01 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-13 | 0001193125-26-347906 |
| us-gaap | IncreaseDecreaseInAccountsReceivable | Increase (Decrease) in Accounts Receivable | USD | 3.69M | 2026-01-01 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-13 | 0001193125-26-347906 |
| us-gaap | IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities | USD | 3.51M | 2026-01-01 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-13 | 0001193125-26-347906 |
| us-gaap | IncreaseDecreaseInContractWithCustomerLiability | Increase (Decrease) in Contract with Customer, Liability | USD | 0 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-02-17 | 0000950170-23-003129 |
| us-gaap | IncreaseDecreaseInDeferredRevenue | Increase (Decrease) in Deferred Revenue | USD | -8.03M | 2018-01-01 | 2018-09-30 | 2018 | Q3 | 10-Q | 2018-11-08 | 0001193125-18-322696 |
| us-gaap | IncreaseDecreaseInDepositOtherAssets | Increase (Decrease) in Deposit Assets | USD | 30,000 | 2008-12-22 | 2013-12-31 | 2013 | FY | 10-K | 2014-03-21 | 0001047469-14-002800 |
| us-gaap | IncreaseDecreaseInInventories | Increase (Decrease) in Inventories | USD | -44,000 | 2026-01-01 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-13 | 0001193125-26-347906 |
| us-gaap | IncreaseDecreaseInOtherNoncurrentAssets | Increase (Decrease) in Other Noncurrent Assets | USD | -11.70M | 2022-01-01 | 2022-03-31 | 2022 | Q1 | 10-Q | 2022-05-05 | 0000950170-22-007564 |
| us-gaap | IncreaseDecreaseInOtherOperatingAssets | Increase (Decrease) in Other Operating Assets | USD | 19.50M | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-01 | 0000950170-22-002548 |
| us-gaap | IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets | Increase (Decrease) in Prepaid Expense and Other Assets | USD | -1.78M | 2026-01-01 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-13 | 0001193125-26-347906 |
| us-gaap | IncreaseDecreaseInPrepaidRent | Increase (Decrease) in Prepaid Rent | USD | -2.65M | 2018-01-01 | 2018-12-31 | 2020 | FY | 10-K | 2021-02-24 | 0001193125-21-054811 |
| us-gaap | IncreaseDecreaseInRestrictedCash | Increase (Decrease) in Restricted Cash | USD | 82,000 | 2015-01-01 | 2015-12-31 | 2017 | FY | 10-K | 2018-03-15 | 0001193125-18-084024 |
| us-gaap | IncreaseInRestrictedCash | Increase in Restricted Cash | USD | 400,000 | 2014-01-01 | 2014-09-30 | 2014 | Q3 | 10-Q | 2014-11-10 | 0001104659-14-078971 |
| us-gaap | InterestExpense | Interest Expense | USD | 14.83M | 2024-01-01 | 2024-06-30 | 2024 | Q2 | 10-Q | 2024-08-06 | 0000950170-24-091210 |
| us-gaap | InterestExpenseLongTermDebt | Interest Expense, Long-term Debt | USD | 11.30M | 2026-01-01 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-13 | 0001193125-26-347906 |
| us-gaap | InterestExpenseNonoperating | InterestExpenseNonoperating | USD | 25.70M | 2026-01-01 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-13 | 0001193125-26-347906 |
| us-gaap | InterestPaidNet | Interest Paid, Excluding Capitalized Interest, Operating Activities | USD | 0 | 2026-01-01 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-13 | 0001193125-26-347906 |
| us-gaap | InterestPayableCurrent | Interest Payable, Current | USD | 10.34M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-13 | 0001193125-26-049397 | |
| us-gaap | InterestPayableCurrentAndNoncurrent | Interest Payable | USD | 23.91M | 2021-12-31 | 2021 | FY | 10-K | 2022-03-01 | 0000950170-22-002548 | |
| us-gaap | InventoryFinishedGoods | Inventory, Finished Goods, Gross | USD | 199,000 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-13 | 0001193125-26-347906 | |
| us-gaap | InventoryNet | Inventory, Net | USD | 3.99M | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-13 | 0001193125-26-347906 | |
| us-gaap | InventoryRawMaterialsAndSupplies | Inventory, Raw Materials and Supplies, Gross | USD | 628,000 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-13 | 0001193125-26-347906 | |
| us-gaap | InventoryValuationReserves | Inventory Valuation Reserves | USD | 400,000 | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-11-03 | 0000950170-21-002729 | |
| us-gaap | InventoryWorkInProcess | Inventory, Work in Process, Gross | USD | 3.17M | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-13 | 0001193125-26-347906 | |
| us-gaap | InventoryWorkInProcessAndRawMaterialsNetOfReserves | Inventory, Work in Process and Raw Materials, Net of Reserves | USD | 1.57M | 2020-09-30 | 2020 | Q3 | 10-Q | 2020-11-02 | 0001564590-20-049664 | |
| us-gaap | InventoryWriteDown | Inventory Write-down | USD | 0 | 2022-01-01 | 2022-03-31 | 2022 | Q1 | 10-Q | 2022-05-05 | 0000950170-22-007564 |
| us-gaap | InvestmentIncomeInterest | Investment Income, Interest | USD | 1.23M | 2026-01-01 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-13 | 0001193125-26-347906 |
| us-gaap | InvestmentsFairValueDisclosure | Investments, Fair Value Disclosure | USD | 231.36M | 2015-06-30 | 2015 | Q2 | 10-Q | 2015-08-10 | 0001193125-15-283822 | |
| us-gaap | LesseeOperatingLeaseDiscountRate | Lessee, Operating Lease, Discount Rate | pure | 0.145 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-13 | 0001193125-26-049397 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDue | Lessee, Operating Lease, Liability, to be Paid | USD | 9.39M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-13 | 0001193125-26-049397 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive | Lessee, Operating Lease, Liability, to be Paid, after Year Five | USD | 1.56M | 2024-12-31 | 2024 | FY | 10-K | 2025-02-19 | 0000950170-25-022765 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths | Lessee, Operating Lease, Liability, to be Paid, Year One | USD | 1.88M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-13 | 0001193125-26-049397 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearFive | Lessee, Operating Lease, Liability, to be Paid, Year Five | USD | 1.56M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-13 | 0001193125-26-049397 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearFour | Lessee, Operating Lease, Liability, to be Paid, Year Four | USD | 2.04M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-13 | 0001193125-26-049397 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearThree | Lessee, Operating Lease, Liability, to be Paid, Year Three | USD | 1.99M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-13 | 0001193125-26-049397 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearTwo | Lessee, Operating Lease, Liability, to be Paid, Year Two | USD | 1.93M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-13 | 0001193125-26-049397 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear | Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year | USD | 793,000 | 2019-09-30 | 2019 | Q3 | 10-Q | 2019-11-04 | 0001193125-19-282510 | |
| us-gaap | LesseeOperatingLeaseLiabilityUndiscountedExcessAmount | Lessee, Operating Lease, Liability, Undiscounted Excess Amount | USD | 2.68M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-13 | 0001193125-26-049397 | |
| us-gaap | Liabilities | Liabilities | USD | 441.49M | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-13 | 0001193125-26-347906 | |
| us-gaap | LiabilitiesAndStockholdersEquity | Liabilities and Equity | USD | 111.32M | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-13 | 0001193125-26-347906 | |
| us-gaap | LiabilitiesCurrent | Liabilities, Current | USD | 134.23M | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-13 | 0001193125-26-347906 | |
| us-gaap | LicenseAndServicesRevenue | License and Services Revenue (Deprecated 2018-01-31) | USD | 10.00M | 2018-01-01 | 2018-03-31 | 2018 | Q1 | 10-Q | 2018-05-10 | 0001193125-18-159200 |
| us-gaap | LongTermDebt | Long-term Debt | USD | 169.29M | 2021-12-31 | 2021 | FY | 10-K | 2022-03-01 | 0000950170-22-002548 | |
| us-gaap | LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths | Long-Term Debt, Maturity, Year One | USD | 5.17M | 2021-12-31 | 2021 | FY | 10-K | 2022-03-01 | 0000950170-22-002548 | |
| us-gaap | LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour | Long-Term Debt, Maturity, Year Four | USD | 177.68M | 2021-12-31 | 2021 | FY | 10-K | 2022-03-01 | 0000950170-22-002548 | |
| us-gaap | LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree | Long-Term Debt, Maturity, Year Three | USD | 5.17M | 2021-12-31 | 2021 | FY | 10-K | 2022-03-01 | 0000950170-22-002548 | |
| us-gaap | LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo | Long-Term Debt, Maturity, Year Two | USD | 5.17M | 2021-12-31 | 2021 | FY | 10-K | 2022-03-01 | 0000950170-22-002548 | |
| us-gaap | LongTermInvestments | Long-term Investments | USD | 10.31M | 2018-03-31 | 2018 | Q1 | 10-Q | 2018-05-10 | 0001193125-18-159200 | |
| us-gaap | MarketableSecuritiesGainLoss | Marketable Securities, Gain (Loss) | USD | 2,000 | 2022-01-01 | 2022-03-31 | 2022 | Q1 | 10-Q | 2022-05-05 | 0000950170-22-007564 |
| us-gaap | NetCashProvidedByUsedInContinuingOperations | Net Cash Provided by (Used in) Continuing Operations | USD | -5.37M | 2014-01-01 | 2014-12-31 | 2014 | FY | 10-K | 2015-03-13 | 0001193125-15-091264 |
| us-gaap | NetCashProvidedByUsedInFinancingActivities | Net Cash Provided by (Used in) Financing Activities | USD | 48.90M | 2026-01-01 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-13 | 0001193125-26-347906 |
| us-gaap | NetCashProvidedByUsedInFinancingActivitiesContinuingOperations | Net Cash Provided by (Used in) Financing Activities, Continuing Operations | USD | 429,000 | 2018-01-01 | 2018-03-31 | 2018 | Q1 | 10-Q | 2018-05-10 | 0001193125-18-159200 |
| us-gaap | NetCashProvidedByUsedInInvestingActivities | Net Cash Provided by (Used in) Investing Activities | USD | -6.84M | 2026-01-01 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-13 | 0001193125-26-347906 |
| us-gaap | NetCashProvidedByUsedInInvestingActivitiesContinuingOperations | Net Cash Provided by (Used in) Investing Activities, Continuing Operations | USD | 2.48M | 2018-01-01 | 2018-03-31 | 2018 | Q1 | 10-Q | 2018-05-10 | 0001193125-18-159200 |
| us-gaap | NetCashProvidedByUsedInOperatingActivities | Net Cash Provided by (Used in) Operating Activities | USD | -47.66M | 2026-01-01 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-13 | 0001193125-26-347906 |
| us-gaap | NetCashProvidedByUsedInOperatingActivitiesContinuingOperations | Net Cash Provided by (Used in) Operating Activities, Continuing Operations | USD | -34.65M | 2018-01-01 | 2018-03-31 | 2018 | Q1 | 10-Q | 2018-05-10 | 0001193125-18-159200 |
| us-gaap | NetIncomeLoss | Net Income (Loss) Attributable to Parent | USD | -89.42M | 2026-01-01 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-13 | 0001193125-26-347906 |
| us-gaap | NetIncomeLossAvailableToCommonStockholdersBasic | Net Income (Loss) Available to Common Stockholders, Basic | USD | -13.57M | 2024-01-01 | 2024-06-30 | 2025 | Q2 | 10-Q | 2025-08-11 | 0000950170-25-106238 |
| us-gaap | NetIncomeLossAvailableToCommonStockholdersDiluted | Net Income (Loss) Available to Common Stockholders, Diluted | USD | -30.55M | 2026-01-01 | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-05-14 | 0001193125-26-222827 |
| us-gaap | NoncashOrPartNoncashAcquisitionPayablesAssumed1 | Noncash or Part Noncash Acquisition, Payables Assumed | USD | 52,000 | 2014-01-01 | 2014-12-31 | 2016 | FY | 10-K | 2017-03-16 | 0001193125-17-084396 |
| us-gaap | NonoperatingIncomeExpense | Nonoperating Income (Expense) | USD | -40.13M | 2026-01-01 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-13 | 0001193125-26-347906 |
| us-gaap | NotesIssued1 | Notes Issued | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-13 | 0001193125-26-049397 |
| us-gaap | NumberOfOperatingSegments | Number of Operating Segments | Segment | 1 | 2026-01-01 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-13 | 0001193125-26-347906 |
| us-gaap | NumberOfReportableSegments | Number of Reportable Segments | Segment | 1 | 2026-01-01 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-13 | 0001193125-26-347906 |
| us-gaap | OperatingCostsAndExpenses | Operating Costs and Expenses | USD | 1.43M | 2022-01-01 | 2022-03-31 | 2022 | Q1 | 10-Q | 2022-05-05 | 0000950170-22-007564 |
| us-gaap | OperatingExpenses | Operating Expenses | USD | 117.78M | 2026-01-01 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-13 | 0001193125-26-347906 |
| us-gaap | OperatingIncomeLoss | Operating Income (Loss) | USD | -49.29M | 2026-01-01 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-13 | 0001193125-26-347906 |
| us-gaap | OperatingLeaseCost | Operating Lease, Cost | USD | 2.80M | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-02-17 | 0000950170-23-003129 |
| us-gaap | OperatingLeaseExpense | Operating Lease, Expense | USD | 2.40M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-13 | 0001193125-26-049397 |
| us-gaap | OperatingLeaseLiability | Operating Lease, Liability | USD | 6.71M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-13 | 0001193125-26-049397 | |
| us-gaap | OperatingLeaseLiabilityCurrent | Operating Lease, Liability, Current | USD | 1.07M | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-13 | 0001193125-26-347906 | |
| us-gaap | OperatingLeaseLiabilityNoncurrent | Operating Lease, Liability, Noncurrent | USD | 5.18M | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-13 | 0001193125-26-347906 | |
| us-gaap | OperatingLeaseRightOfUseAsset | Operating Lease, Right-of-Use Asset | USD | 4.26M | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-13 | 0001193125-26-347906 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDue | Operating Leases, Future Minimum Payments Due | USD | 23.43M | 2018-12-31 | 2018 | FY | 10-K | 2019-02-28 | 0001193125-19-057610 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueCurrent | Operating Leases, Future Minimum Payments Due, Next Twelve Months | USD | 3.05M | 2018-12-31 | 2018 | FY | 10-K | 2019-02-28 | 0001193125-19-057610 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueInFiveYears | Operating Leases, Future Minimum Payments, Due in Five Years | USD | 3.72M | 2018-12-31 | 2018 | FY | 10-K | 2019-02-28 | 0001193125-19-057610 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueInFourYears | Operating Leases, Future Minimum Payments, Due in Four Years | USD | 3.45M | 2018-12-31 | 2018 | FY | 10-K | 2019-02-28 | 0001193125-19-057610 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueInThreeYears | Operating Leases, Future Minimum Payments, Due in Three Years | USD | 3.28M | 2018-12-31 | 2018 | FY | 10-K | 2019-02-28 | 0001193125-19-057610 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueInTwoYears | Operating Leases, Future Minimum Payments, Due in Two Years | USD | 3.21M | 2018-12-31 | 2018 | FY | 10-K | 2019-02-28 | 0001193125-19-057610 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueThereafter | Operating Leases, Future Minimum Payments, Due Thereafter | USD | 6.74M | 2018-12-31 | 2018 | FY | 10-K | 2019-02-28 | 0001193125-19-057610 | |
| us-gaap | OperatingLeasesRentExpenseContingentRentals | Operating Leases, Rent Expense, Contingent Rentals | USD | 898,000 | 2014-03-01 | 2014-03-31 | 2014 | Q3 | 10-Q | 2014-11-10 | 0001104659-14-078971 |
| us-gaap | OperatingLeasesRentExpenseMinimumRentals | Operating Leases, Rent Expense, Minimum Rentals | USD | 506,000 | 2014-03-01 | 2014-03-31 | 2014 | Q3 | 10-Q | 2014-11-10 | 0001104659-14-078971 |
| us-gaap | OperatingLeasesRentExpenseNet | Operating Leases, Rent Expense, Net | USD | 2.48M | 2018-01-01 | 2018-12-31 | 2018 | FY | 10-K | 2019-02-28 | 0001193125-19-057610 |
| us-gaap | OtherAccruedLiabilitiesCurrent | Other Accrued Liabilities, Current | USD | 4.61M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-13 | 0001193125-26-049397 | |
| us-gaap | OtherAssets | Other Assets | USD | 267,000 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-13 | 0001193125-26-347906 | |
| us-gaap | OtherAssetsCurrent | Other Assets, Current | USD | 31.47M | 2022-09-30 | 2022 | Q3 | 10-Q | 2022-11-03 | 0000950170-22-021917 | |
| us-gaap | OtherAssetsNoncurrent | Other Assets, Noncurrent | USD | 15,000 | 2017-03-31 | 2017 | Q1 | 10-Q | 2017-05-04 | 0001193125-17-158670 | |
| us-gaap | OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax | Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax | USD | -25,000 | 2026-01-01 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-13 | 0001193125-26-347906 |
| us-gaap | OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax | OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax | USD | -5,000 | 2026-01-01 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-13 | 0001193125-26-347906 |
| us-gaap | OtherIncome | Other Income | USD | 6.00M | 2021-01-01 | 2021-12-31 | 2023 | FY | 10-K | 2024-02-29 | 0000950170-24-022650 |
| us-gaap | OtherLiabilitiesCurrent | Other Liabilities, Current | USD | 6.39M | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-13 | 0001193125-26-347906 | |
| us-gaap | OtherLiabilitiesNoncurrent | Other Liabilities, Noncurrent | USD | 336,000 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-13 | 0001193125-26-347906 | |
| us-gaap | OtherNoncashIncomeExpense | Other Noncash Income (Expense) | USD | 0 | 2024-01-01 | 2024-03-31 | 2024 | Q1 | 10-Q | 2024-05-08 | 0000950170-24-055672 |
| us-gaap | OtherNonoperatingExpense | Other Nonoperating Expense | USD | 7,000 | 2015-01-01 | 2015-06-30 | 2015 | Q2 | 10-Q | 2015-08-10 | 0001193125-15-283822 |
| us-gaap | OtherNonoperatingIncomeExpense | Other Nonoperating Income (Expense) | USD | -15.66M | 2026-01-01 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-13 | 0001193125-26-347906 |
| us-gaap | PaidInKindInterest | Paid-in-Kind Interest | USD | 188,000 | 2008-12-22 | 2014-03-31 | 2014 | Q1 | 10-Q | 2014-05-08 | 0001104659-14-036479 |
| us-gaap | ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic | Participating Securities, Distributed and Undistributed Earnings (Loss), Basic | USD | 0 | 2024-01-01 | 2024-06-30 | 2025 | Q2 | 10-Q | 2025-08-11 | 0000950170-25-106238 |
| us-gaap | PaymentOfFinancingAndStockIssuanceCosts | Payment of Financing and Stock Issuance Costs | USD | 1.90M | 2026-01-01 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-13 | 0001193125-26-347906 |
| us-gaap | PaymentsForProceedsFromInvestments | Payments for (Proceeds from) Investments | USD | 63.80M | 2014-01-01 | 2014-12-31 | 2014 | FY | 10-K | 2015-03-13 | 0001193125-15-091264 |
| us-gaap | PaymentsForRoyalties | Payments for Royalties | USD | 0 | 2026-01-01 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-13 | 0001193125-26-347906 |
| us-gaap | PaymentsOfDebtIssuanceCosts | Payments of Debt Issuance Costs | USD | 0 | 2025-01-01 | 2025-09-30 | 2025 | Q3 | 10-Q | 2025-11-03 | 0001193125-25-261667 |
| us-gaap | PaymentsOfStockIssuanceCosts | Payments of Stock Issuance Costs | USD | 427,000 | 2014-01-01 | 2014-06-30 | 2015 | Q2 | 10-Q | 2015-08-10 | 0001193125-15-283822 |
| us-gaap | PaymentsRelatedToTaxWithholdingForShareBasedCompensation | Payment, Tax Withholding, Share-based Payment Arrangement | USD | 39,000 | 2016-01-01 | 2016-12-31 | 2018 | FY | 10-K | 2019-02-28 | 0001193125-19-057610 |
| us-gaap | PaymentsToAcquireAvailableForSaleSecuritiesDebt | Payments to Acquire Debt Securities, Available-for-sale | USD | 10.04M | 2026-01-01 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-13 | 0001193125-26-347906 |
| us-gaap | PaymentsToAcquireInProcessResearchAndDevelopment | Payments to Acquire in Process Research and Development | USD | 0 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-02-29 | 0000950170-24-022650 |
| us-gaap | PaymentsToAcquireInvestments | Payments to Acquire Investments | USD | 24.74M | 2018-01-01 | 2018-03-31 | 2018 | Q1 | 10-Q | 2018-05-10 | 0001193125-18-159200 |
| us-gaap | PaymentsToAcquirePropertyPlantAndEquipment | Payments to Acquire Property, Plant, and Equipment | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-13 | 0001193125-26-049397 |
| us-gaap | PreferredStockParOrStatedValuePerShare | Preferred Stock, Par or Stated Value Per Share | USD/shares | 0 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-13 | 0001193125-26-347906 | |
| us-gaap | PreferredStockSharesAuthorized | Preferred Stock, Shares Authorized | shares | 5.00M | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-13 | 0001193125-26-347906 | |
| us-gaap | PreferredStockSharesIssued | Preferred Stock, Shares Issued | shares | 0 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-13 | 0001193125-26-347906 | |
| us-gaap | PreferredStockSharesOutstanding | Preferred Stock, Shares Outstanding | shares | 0 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-13 | 0001193125-26-347906 | |
| us-gaap | PreferredStockValue | Preferred Stock, Value, Issued | USD | 0 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-13 | 0001193125-26-347906 | |
| us-gaap | PrepaidExpenseAndOtherAssetsCurrent | Prepaid Expense and Other Assets, Current | USD | 7.41M | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-13 | 0001193125-26-347906 | |
| us-gaap | PrepaidExpenseCurrent | Prepaid Expense, Current | USD | 10.05M | 2022-09-30 | 2022 | Q3 | 10-Q | 2022-11-03 | 0000950170-22-021917 | |
| us-gaap | ProceedsFromConvertibleDebt | Proceeds from Convertible Debt | USD | 15.00M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-13 | 0001193125-26-049397 |
| us-gaap | ProceedsFromDebtNetOfIssuanceCosts | Proceeds from Debt, Net of Issuance Costs | USD | 166.88M | 2018-01-01 | 2018-12-31 | 2018 | FY | 10-K | 2019-02-28 | 0001193125-19-057610 |
| us-gaap | ProceedsFromIssuanceInitialPublicOffering | Proceeds from Issuance Initial Public Offering | USD | 113.20M | 2013-12-01 | 2013-12-31 | 2013 | FY | 10-K | 2014-03-21 | 0001047469-14-002800 |
| us-gaap | ProceedsFromIssuanceOfCommonStock | Proceeds from Issuance of Common Stock | USD | 20.23M | 2026-01-01 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-13 | 0001193125-26-347906 |
| us-gaap | ProceedsFromIssuanceOfPreferredStockAndPreferenceStock | Proceeds from Issuance of Preferred Stock and Preference Stock | USD | 2.00M | 2012-01-01 | 2012-12-31 | 2014 | FY | 10-K | 2015-03-13 | 0001193125-15-091264 |
| us-gaap | ProceedsFromIssuanceOfSecuredDebt | Proceeds from Issuance of Secured Debt | USD | 12.25M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-13 | 0001193125-26-049397 |
| us-gaap | ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions | Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised | USD | 574,000 | 2026-01-01 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-13 | 0001193125-26-347906 |
| us-gaap | ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities | Proceeds from Sale and Maturity of Debt Securities, Available-for-sale | USD | 3.20M | 2026-01-01 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-13 | 0001193125-26-347906 |
| us-gaap | ProceedsFromSaleMaturityAndCollectionsOfInvestments | Proceeds from Sale, Maturity and Collection of Investments | USD | 27.60M | 2018-01-01 | 2018-03-31 | 2018 | Q1 | 10-Q | 2018-05-10 | 0001193125-18-159200 |
| us-gaap | ProceedsFromStockOptionsExercised | Proceeds from Stock Options Exercised | USD | 0 | 2023-01-01 | 2023-03-31 | 2023 | Q1 | 10-Q | 2023-05-04 | 0000950170-23-017483 |
| us-gaap | ProfitLoss | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | USD | -89.42M | 2026-01-01 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-13 | 0001193125-26-347906 |
| us-gaap | PropertyPlantAndEquipmentGross | Property, Plant and Equipment, Gross | USD | 5.61M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-13 | 0001193125-26-049397 | |
| us-gaap | PropertyPlantAndEquipmentNet | Property, Plant and Equipment, Net | USD | 94,000 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-13 | 0001193125-26-347906 | |
| us-gaap | ReceivablesNetCurrent | Receivables, Net, Current | USD | 29.87M | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-13 | 0001193125-26-347906 | |
| us-gaap | RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty | Related Party Transaction, Expenses from Transactions with Related Party | USD | 1.42M | 2008-12-22 | 2013-12-31 | 2013 | FY | 10-K | 2014-03-21 | 0001047469-14-002800 |
| us-gaap | RepaymentsOfConvertibleDebt | Repayments of Convertible Debt | USD | 250,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-13 | 0001193125-26-049397 |
| us-gaap | ResearchAndDevelopmentExpense | Research and Development Expense | USD | 62.75M | 2026-01-01 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-13 | 0001193125-26-347906 |
| us-gaap | ResearchAndDevelopmentInProcess | Research and Development in Process | USD | 0 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-02-17 | 0000950170-23-003129 |
| us-gaap | RestrictedCashAndCashEquivalentsAtCarryingValue | Restricted Cash and Cash Equivalents, Current | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-13 | 0001193125-26-049397 | |
| us-gaap | RestrictedCashAndCashEquivalentsNoncurrent | Restricted Cash and Cash Equivalents, Noncurrent | USD | 318,000 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-13 | 0001193125-26-347906 | |
| us-gaap | RetainedEarningsAccumulatedDeficit | Retained Earnings (Accumulated Deficit) | USD | -1.85B | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-13 | 0001193125-26-347906 | |
| us-gaap | RevenueFromContractWithCustomerExcludingAssessedTax | Revenue from Contract with Customer, Excluding Assessed Tax | USD | 68.50M | 2026-01-01 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-13 | 0001193125-26-347906 |
| us-gaap | RevenueFromContractWithCustomerIncludingAssessedTax | Revenue from Contract with Customer, Including Assessed Tax | USD | 20.00M | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-01 | 0000950170-22-002548 |
| us-gaap | RevenueFromGrants | Revenue from Grants (Deprecated 2018-01-31) | USD | 71,000 | 2017-01-01 | 2017-09-30 | 2017 | Q3 | 10-Q | 2017-11-02 | 0001564590-17-021223 |
| us-gaap | RevenueRecognitionMilestoneMethodRevenueRecognized | Revenue Recognition, Milestone Method, Revenue Recognized | USD | 21.92M | 2017-01-01 | 2017-12-31 | 2017 | FY | 10-K | 2018-03-15 | 0001193125-18-084024 |
| us-gaap | RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability | USD | 11.71M | 2019-01-01 | 2019-12-31 | 2021 | FY | 10-K | 2022-03-01 | 0000950170-22-002548 |
| us-gaap | SalesRevenueNet | Revenue, Net (Deprecated 2018-01-31) | USD | 68,000 | 2017-01-01 | 2017-03-31 | 2017 | Q1 | 10-Q | 2017-05-04 | 0001193125-17-158670 |
| us-gaap | SecuredDebtCurrent | Secured Debt, Current | USD | 40.31M | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-13 | 0001193125-26-347906 | |
| us-gaap | SecuredLongTermDebt | Secured Long-term Debt, Noncurrent | USD | 85.05M | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-13 | 0001193125-26-347906 | |
| us-gaap | SecurityDeposit | Security Deposit | USD | 200,000 | 2018-01-31 | 2018 | Q1 | 10-Q | 2018-05-10 | 0001193125-18-159200 | |
| us-gaap | SellingGeneralAndAdministrativeExpense | Selling, General and Administrative Expense | USD | 52.60M | 2026-01-01 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-13 | 0001193125-26-347906 |
| us-gaap | ShareBasedCompensation | Share-based Payment Arrangement, Noncash Expense | USD | 4.94M | 2026-01-01 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-13 | 0001193125-26-347906 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period | shares | 1.96M | 2018-01-01 | 2018-12-31 | 2018 | FY | 10-K | 2019-02-28 | 0001193125-19-057610 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized | Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized | shares | 1.68M | 2017-12-31 | 2017 | FY | 10-K | 2018-03-15 | 0001193125-18-084024 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period | shares | 5.74M | 2026-01-01 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-13 | 0001193125-26-347906 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price | USD/shares | 59.06 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-13 | 0001193125-26-347906 | |
| us-gaap | SharePrice | Share Price | USD/shares | 42.5 | 2014-07-31 | 2014 | Q3 | 10-Q | 2014-11-10 | 0001104659-14-078971 | |
| us-gaap | ShortTermInvestments | Short-term Investments | USD | 93.42M | 2018-03-31 | 2018 | Q1 | 10-Q | 2018-05-10 | 0001193125-18-159200 | |
| us-gaap | StockholdersEquity | Stockholders' Equity Attributable to Parent | USD | -330.17M | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-13 | 0001193125-26-347906 | |
| us-gaap | StockholdersEquityNoteStockSplitConversionRatio1 | Stockholders' Equity Note, Stock Split, Conversion Ratio | pure | 0.303 | 2013-10-01 | 2013-10-31 | 2013 | FY | 10-K | 2014-03-21 | 0001047469-14-002800 |
| us-gaap | StockIssued1 | Stock Issued | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-13 | 0001193125-26-049397 |
| us-gaap | StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities | Stock Issued During Period, Shares, Conversion of Convertible Securities | shares | 3.10M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-13 | 0001193125-26-049397 |
| us-gaap | StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans | Stock Issued During Period, Shares, Employee Stock Purchase Plans | shares | 46,815 | 2016-01-01 | 2016-12-31 | 2016 | FY | 10-K | 2017-03-16 | 0001193125-17-084396 |
| us-gaap | StockIssuedDuringPeriodSharesNewIssues | Stock Issued During Period, Shares, New Issues | shares | 2.45M | 2014-07-01 | 2014-07-31 | 2014 | Q3 | 10-Q | 2014-11-10 | 0001104659-14-078971 |
| us-gaap | StockIssuedDuringPeriodSharesStockOptionsExercised | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period | shares | 397,087 | 2014-07-01 | 2014-07-31 | 2014 | Q3 | 10-Q | 2014-11-10 | 0001104659-14-078971 |
| us-gaap | StockIssuedDuringPeriodValueEmployeeStockPurchasePlan | Stock Issued During Period, Value, Employee Stock Purchase Plan | USD | 340,000 | 2016-01-01 | 2016-12-31 | 2016 | FY | 10-K | 2017-03-16 | 0001193125-17-084396 |
| us-gaap | StockIssuedDuringPeriodValueNewIssues | Stock Issued During Period, Value, New Issues | USD | 189.76M | 2022-01-01 | 2022-12-31 | 2024 | FY | 10-K | 2025-02-19 | 0000950170-25-022765 |
| us-gaap | StockIssuedDuringPeriodValueOther | Stock Issued During Period, Value, Other | USD | 6.93M | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-02-13 | 0001193125-26-049397 |
| us-gaap | StockIssuedDuringPeriodValuePurchaseOfAssets | Stock Issued During Period, Value, Purchase of Assets | USD | 1.35M | 2021-01-01 | 2021-12-31 | 2023 | FY | 10-K | 2024-02-29 | 0000950170-24-022650 |
| us-gaap | StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures | Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures | USD | 0 | 2021-01-01 | 2021-06-30 | 2021 | Q2 | 10-Q | 2021-08-05 | 0000950170-21-000948 |
| us-gaap | StockIssuedDuringPeriodValueStockOptionsExercised | Stock Issued During Period, Value, Stock Options Exercised | USD | 574,000 | 2026-01-01 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-13 | 0001193125-26-347906 |
| us-gaap | TemporaryEquityCarryingAmountAttributableToParent | Temporary Equity, Carrying Amount, Attributable to Parent | USD | 18.28M | 2012-12-31 | 2013 | FY | 10-K | 2014-03-21 | 0001047469-14-002800 | |
| us-gaap | TemporaryEquitySharesOutstanding | Temporary Equity, Shares Outstanding | shares | 0 | 2013-12-31 | 2013 | FY | 10-K | 2014-03-21 | 0001047469-14-002800 | |
| us-gaap | TenantImprovements | Tenant Improvements | USD | 1.62M | 2015-03-31 | 2017 | FY | 10-K | 2018-03-15 | 0001193125-18-084024 | |
| us-gaap | UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued | Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-13 | 0001193125-26-049397 | |
| us-gaap | UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense | Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-13 | 0001193125-26-049397 |
| us-gaap | ValuationAllowanceDeferredTaxAssetChangeInAmount | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount | USD | 133.80M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-13 | 0001193125-26-049397 |
| us-gaap | WeightedAverageNumberOfDilutedSharesOutstanding | Weighted Average Number of Shares Outstanding, Diluted | shares | 25,495 | 2026-01-01 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-13 | 0001193125-26-347906 |
| us-gaap | WeightedAverageNumberOfShareOutstandingBasicAndDiluted | Weighted Average Number of Shares Outstanding, Basic and Diluted | shares | 77.57M | 2022-01-01 | 2022-03-31 | 2022 | Q1 | 10-Q | 2022-05-05 | 0000950170-22-007564 |
| us-gaap | WeightedAverageNumberOfSharesOutstandingBasic | Weighted Average Number of Shares Outstanding, Basic | shares | 25,495 | 2026-01-01 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-13 | 0001193125-26-347906 |